Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transcription factor binding	TRERF1 HDAC9 NCOA6 ZBTB16 NACA GATA2 BBS1 MEF2D TCERG1 PTPRN ARNT2 NFYA KMT2A CHD6 BSN HSF1 FOXF2 PCLO NSD1 CREB1 CREM CCNT2 EGR2 NKX2-1 ARID2 MED25 CNOT1 CRTC2 HR	5.20e-09	753	221	29	GO:0008134
GeneOntologyMolecularFunction	transcription coregulator binding	TRERF1 ZBTB16 GATA2 NFYA CHD6 BSN PCLO CREB1 CCNT2 NKX2-1 MED25	4.62e-07	140	221	11	GO:0001221
GeneOntologyMolecularFunction	RNA polymerase II-specific DNA-binding transcription factor binding	TRERF1 HDAC9 NCOA6 GATA2 BBS1 MEF2D TCERG1 ARNT2 HSF1 NSD1 CREB1 EGR2 NKX2-1 MED25 CNOT1 HR	1.76e-05	417	221	16	GO:0061629
GeneOntologyMolecularFunction	DNA-binding transcription factor binding	TRERF1 HDAC9 NCOA6 GATA2 BBS1 MEF2D TCERG1 ARNT2 KMT2A HSF1 NSD1 CREB1 CREM EGR2 NKX2-1 MED25 CNOT1 CRTC2 HR	2.75e-05	582	221	19	GO:0140297
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	ZNF280A POU6F2 ZBTB16 HIVEP2 CIART BACH2 GATA2 RREB1 MEF2D TLX1 ARNT2 NFYA KLF17 HSF1 MNT FOXF2 NPAS2 NSD1 E2F2 CREB1 CREM CREB5 KLF10 ZFHX4 EGR2 NKX2-1 ZNF335 ZFHX3 PBX3	1.18e-04	1244	221	29	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	ZNF280A POU6F2 ZBTB16 HIVEP2 CIART BACH2 GATA2 RREB1 MEF2D TLX1 ARNT2 NFYA KLF17 HSF1 MNT FOXF2 NPAS2 NSD1 E2F2 CREB1 CREM CREB5 KLF10 ZFHX4 EGR2 NKX2-1 ZNF335 ZFHX3 PBX3	1.71e-04	1271	221	29	GO:0000987
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	ZBTB16 HIVEP2 GATA2 RREB1 MEF2D TLX1 ARNT2 NFYA HSF1 FOXF2 E2F2 CREB1 CREB5 KLF10 EGR2 NKX2-1 PBX3	1.76e-04	560	221	17	GO:0001228
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	ZBTB16 HIVEP2 GATA2 RREB1 MEF2D TLX1 ARNT2 NFYA HSF1 FOXF2 E2F2 CREB1 CREB5 KLF10 EGR2 NKX2-1 PBX3	1.99e-04	566	221	17	GO:0001216
GeneOntologyMolecularFunction	transcription coactivator binding	TRERF1 GATA2 CREB1 CCNT2 MED25	3.23e-04	54	221	5	GO:0001223
GeneOntologyMolecularFunction	tyrosine-ester sulfotransferase activity	SULT1A2 SULT1A1	7.21e-04	4	221	2	GO:0017067
GeneOntologyMolecularFunction	amine sulfotransferase activity	SULT1A2 SULT1A1	7.21e-04	4	221	2	GO:0047685
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	TRERF1 NCOA6 ZBTB16 HIVEP2 NACA GATA2 MAML1 RAD54L2 RREB1 MEF2D TLX1 NOD2 TCERG1 PTPRN ARNT2 NFYA KMT2A FGF4 CHD6 HSF1 FOXF2 NPAS2 E2F2 CREB1 CREM CREB5 CCNT2 PWWP2B SF3B1 KLF10 EGFR EGR2 NKX2-1 ARID2 ZNF335 MED25 ZFHX3 PBX3 CRTC2	2.46e-08	1390	220	39	GO:0045944
GeneOntologyCellularComponent	transcription regulator complex	TRERF1 HDAC9 NCOA6 ZBTB16 HIVEP2 BACH2 GATA2 ARNT2 NFYA FOXF2 NPAS2 E2F2 CREB1 CREM NKX2-1 TRIM28 ARID2 MED25 ZFHX3 PBX3	5.81e-06	596	221	20	GO:0005667
GeneOntologyCellularComponent	chromatin	POU6F2 TSHZ2 BACH2 MEF2D TLX1 ARNT2 NFYA KLF17 CHD6 HSF1 MNT FOXF2 NPAS2 CECR2 NSD1 E2F2 CREB1 CREM CREB5 PHC1 PHC2 RIF1 SF3B1 KLF10 ZFHX4 EGR2 NKX2-1 TRIM28 ARID2 ZFHX3 PBX3 AFF4 HR	3.74e-05	1480	221	33	GO:0000785
GeneOntologyCellularComponent	histone methyltransferase complex	HDAC9 NCOA6 KMT2B KMT2A NSD1 ZNF335	1.43e-04	75	221	6	GO:0035097
GeneOntologyCellularComponent	somatodendritic compartment	CLSTN3 MAP6 INHA DAB1 CKAP5 VPS16 EFHC1 HMCN2 SNAP91 PTPRN ARHGAP44 BSN MPL CACNA1C SYNE1 PCLO ITSN1 PABPC1 CCK SHANK2 NPTXR SIPA1L1 LRP4 TMEM108 MDGA1 INPP5J	5.87e-04	1228	221	26	GO:0036477
GeneOntologyCellularComponent	ATF4-CREB1 transcription factor complex	CREB1 CREM	6.58e-04	4	221	2	GO:1990589
GeneOntologyCellularComponent	nuclear protein-containing complex	TRERF1 HDAC9 NCOA6 KMT2B BACH2 CPSF4 NFYA KMT2A NPAS2 SYNE1 CECR2 NSD1 E2F2 CREB1 PABPC1 CREM PHC1 PHC2 CCNT2 SF3B1 NUP155 TRIM28 ARID2 ZNF335 MED25 POM121B AFF4 HR	6.74e-04	1377	221	28	GO:0140513
GeneOntologyCellularComponent	cell surface	CLSTN3 LILRB2 ITGA2B DCC ULBP3 NOD2 SIRPG BTN3A3 UMODL1 PVR BSN MPL CACNA1C LILRA2 MUC16 ACVR1C BTN3A2 BTN3A1 MST1R EGFR LRP4 CD79A MDGA1 GPRC5B	7.28e-04	1111	221	24	GO:0009986
GeneOntologyCellularComponent	presynaptic endocytic zone	SNAP91 ITSN1 FCHO2	8.46e-04	18	221	3	GO:0098833
GeneOntologyCellularComponent	euchromatin	HSF1 CECR2 CREB1 TRIM28 AFF4	9.94e-04	72	221	5	GO:0000791
GeneOntologyCellularComponent	methyltransferase complex	HDAC9 NCOA6 KMT2B KMT2A NSD1 ZNF335	1.02e-03	108	221	6	GO:0034708
Domain	IG	LILRB2 DCC SIRPG BTN3A3 HMCN2 PVR ALPK3 LILRA2 MYOM3 BTN3A2 BTN3A1 NCAN CD79A MYOM2 MDGA1 ALPK2	3.52e-05	421	217	16	SM00409
Domain	Ig_sub	LILRB2 DCC SIRPG BTN3A3 HMCN2 PVR ALPK3 LILRA2 MYOM3 BTN3A2 BTN3A1 NCAN CD79A MYOM2 MDGA1 ALPK2	3.52e-05	421	217	16	IPR003599
Domain	Ig-like_fold	LILRB2 DCC SIRPG BTN3A3 HMCN2 UMODL1 PVR ALPK3 MPL LILRA2 MYOM3 FNDC3A BTN3A2 BTN3A1 MST1R SHANK2 NCAN CD79A MYOM2 MDGA1 ALPK2	7.96e-05	706	217	21	IPR013783
Domain	MeTrfase_trithorax	KMT2B KMT2A	1.34e-04	2	217	2	IPR016569
Domain	Znf_piccolo	BSN PCLO	1.34e-04	2	217	2	IPR008899
Domain	zf-piccolo	BSN PCLO	1.34e-04	2	217	2	PF05715
Domain	IG_LIKE	LILRB2 DCC SIRPG BTN3A3 HMCN2 PVR ALPK3 LILRA2 MYOM3 BTN3A2 BTN3A1 NCAN CD79A MYOM2 MDGA1 ALPK2	2.10e-04	491	217	16	PS50835
Domain	Ig-like_dom	LILRB2 DCC SIRPG BTN3A3 HMCN2 PVR ALPK3 LILRA2 MYOM3 BTN3A2 BTN3A1 NCAN CD79A MYOM2 MDGA1 ALPK2	2.76e-04	503	217	16	IPR007110
Domain	pKID	CREB1 CREM	4.00e-04	3	217	2	PF02173
Domain	KID	CREB1 CREM	4.00e-04	3	217	2	PS50953
Domain	Coactivator_CBP_pKID	CREB1 CREM	4.00e-04	3	217	2	IPR003102
Domain	bZIP_1	BACH2 CREB1 CREM CREB5	6.25e-04	34	217	4	PF00170
Domain	-	DCC SIRPG BTN3A3 UMODL1 PVR ALPK3 MPL LILRA2 MYOM3 FNDC3A BTN3A2 BTN3A1 MST1R NCAN CD79A MYOM2 MDGA1 ALPK2	7.65e-04	663	217	18	2.60.40.10
Domain	Post-SET_dom	KMT2B KMT2A NSD1	7.75e-04	16	217	3	IPR003616
Domain	PostSET	KMT2B KMT2A NSD1	7.75e-04	16	217	3	SM00508
Domain	AT_hook	KMT2A CECR2 SETBP1	7.75e-04	16	217	3	PF02178
Domain	POST_SET	KMT2B KMT2A NSD1	7.75e-04	16	217	3	PS50868
Domain	Leuzip_CREB	CREB1 CREM	7.94e-04	4	217	2	IPR001630
Domain	TF_DNA-bd	BACH2 CREB1 CREM CREB5	8.67e-04	37	217	4	IPR008917
Domain	FYrich_C	KMT2B KMT2A	1.31e-03	5	217	2	IPR003889
Domain	FYrich_N	KMT2B KMT2A	1.31e-03	5	217	2	IPR003888
Domain	FYRC	KMT2B KMT2A	1.31e-03	5	217	2	SM00542
Domain	FYRN	KMT2B KMT2A	1.31e-03	5	217	2	SM00541
Domain	Znf_FCS	PHC1 PHC2	1.31e-03	5	217	2	IPR012313
Domain	PolyA	PABPC1 PABPC1L	1.31e-03	5	217	2	SM00517
Domain	-	PABPC1 PABPC1L	1.31e-03	5	217	2	1.10.1900.10
Domain	PABP	PABPC1 PABPC1L	1.31e-03	5	217	2	PF00658
Domain	PABP_1234	PABPC1 PABPC1L	1.31e-03	5	217	2	IPR006515
Domain	FYRN	KMT2B KMT2A	1.31e-03	5	217	2	PF05964
Domain	FYRC	KMT2B KMT2A	1.31e-03	5	217	2	PF05965
Domain	PABC	PABPC1 PABPC1L	1.31e-03	5	217	2	PS51309
Domain	FYRC	KMT2B KMT2A	1.31e-03	5	217	2	PS51543
Domain	FYRN	KMT2B KMT2A	1.31e-03	5	217	2	PS51542
Domain	PABP_HYD	PABPC1 PABPC1L	1.31e-03	5	217	2	IPR002004
Domain	Znf_FYVE_PHD	KMT2B KMT2A BSN PCLO NSD1 DIDO1 TRIM28	1.67e-03	147	217	7	IPR011011
Domain	IGc2	DCC HMCN2 ALPK3 LILRA2 MYOM3 CD79A MYOM2 MDGA1 ALPK2	1.76e-03	235	217	9	SM00408
Domain	Ig_sub2	DCC HMCN2 ALPK3 LILRA2 MYOM3 CD79A MYOM2 MDGA1 ALPK2	1.76e-03	235	217	9	IPR003598
Domain	PHD	KMT2B KMT2A NSD1 DIDO1 TRIM28	1.80e-03	75	217	5	PF00628
Domain	IGv	SIRPG BTN3A3 PVR BTN3A2 BTN3A1	1.80e-03	75	217	5	SM00406
Domain	PDZ	AHNAK PCLO GORASP2 SHANK2 SIPA1L1 SDCBP2 AHNAK2	1.95e-03	151	217	7	PS50106
Domain	Sec23/24_helical_dom	SEC23B SEC24C	1.95e-03	6	217	2	IPR006900
Domain	Alpha_kinase	ALPK3 ALPK2	1.95e-03	6	217	2	PF02816
Domain	Sec23_24_beta_S	SEC23B SEC24C	1.95e-03	6	217	2	IPR012990
Domain	zf-Sec23_Sec24	SEC23B SEC24C	1.95e-03	6	217	2	PF04810
Domain	Sec23_trunk	SEC23B SEC24C	1.95e-03	6	217	2	PF04811
Domain	Sec23_helical	SEC23B SEC24C	1.95e-03	6	217	2	PF04815
Domain	ZF_FCS	PHC1 PHC2	1.95e-03	6	217	2	PS51024
Domain	MHCK_EF2_kinase	ALPK3 ALPK2	1.95e-03	6	217	2	IPR004166
Domain	Ubiquilin	UBQLN1 UBQLN3	1.95e-03	6	217	2	IPR015496
Domain	Sec23_BS	SEC23B SEC24C	1.95e-03	6	217	2	PF08033
Domain	ALPHA_KINASE	ALPK3 ALPK2	1.95e-03	6	217	2	PS51158
Domain	Alpha_kinase	ALPK3 ALPK2	1.95e-03	6	217	2	SM00811
Domain	Sec23/24_trunk_dom	SEC23B SEC24C	1.95e-03	6	217	2	IPR006896
Domain	Znf_Sec23_Sec24	SEC23B SEC24C	1.95e-03	6	217	2	IPR006895
Domain	PDZ	AHNAK PCLO GORASP2 SHANK2 SIPA1L1 SDCBP2 AHNAK2	2.03e-03	152	217	7	IPR001478
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	NCOA6 EPPK1 HIVEP2 GBF1 KMT2B GATA2 MAML1 NOD2 PHLDB1 TNRC18 SBF1 AHNAK ARHGAP44 BANP TIGD3 UNKL DOCK6 CPVL TRAPPC9 COL4A5 MYOM3 NSD1 BTN3A2 PHC2 MST1R PWWP2B SHANK2 KLF10 TRIM28 ZNF335 LRP4 FUT1 AHNAK2 HR	4.34e-14	1105	224	34	35748872
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TRERF1 IRF2BP2 NCOA6 GBF1 KMT2B MAP4 CKAP5 RREB1 MEF2D KMT2A HSF1 BAG6 OTUD5 ITSN1 RALGAPB DIDO1 PATL1 PHC2 CCNT2 RIF1 PWWP2B SF3B1 SEC24C EGFR TRIM28 SIPA1L1 ZNF335	1.27e-12	774	224	27	15302935
Pubmed	A census of human transcription factors: function, expression and evolution.	TRERF1 POU6F2 HIVEP2 TSHZ2 BACH2 GATA2 RREB1 MEF2D TLX1 ARNT2 NFYA KMT2A UNKL HSF1 MNT FOXF2 NPAS2 E2F2 CREB1 CREM CREB5 KLF10 ZFHX4 EGR2 NKX2-1 ZNF335 SETBP1 ZFHX3 PBX3	1.54e-12	908	224	29	19274049
Pubmed	Human transcription factor protein interaction networks.	TRERF1 IRF2BP2 NCOA6 KMT2B NACA GATA2 MAML1 RAD54L2 RREB1 MEF2D TLX1 CPSF4 TCERG1 BANP NFYA KMT2A CHD6 CPVL MNT TRAPPC9 SEC23B KIFC1 DIDO1 PATL1 CREB1 PABPC1 RIF1 KLF10 ZFHX4 ARID2 SLC25A13 ZFHX3 PABPC1L CNOT1	5.18e-11	1429	224	34	35140242
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	TRERF1 NCOA6 EPPK1 GBF1 RAD54L2 TNRC18 BSN UBQLN1 ITSN1 PABPC1 FAM193A NUP155 EGR2 ARID2 UBQLN3 SETBP1 SDCBP2 GPRC5B CRTC2	6.32e-11	430	224	19	35044719
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	NCOA6 ZBTB16 HIVEP2 GBF1 MAP4 CKAP5 ARHGEF17 MEF2D USP31 PHLDB1 SBF1 TCERG1 STARD9 AHNAK KMT2A DOCK6 TRAPPC9 SEC23B RALGAPB USP43 PABPC1 IPO9 PLEKHG3 SIPA1L1 CRTC2 AHNAK2	8.10e-11	861	224	26	36931259
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	POU6F2 ZBTB16 HIVEP2 GALNT2 MAP4 TSHZ2 DAB1 SLC10A7 PHLDB1 TNRC18 SMPDL3B ARHGAP44 PVR BANP CHD6 DOCK6 TRAPPC9 NPAS2 COL4A5 CACNA1C RALGAPB AHCYL2 PATL1 PWWP2B SHANK2 EGFR PLEKHG3 SETBP1 ZFHX3 GREB1 PBX3 CNOT1 AFF4	6.26e-10	1489	224	33	28611215
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	TRERF1 BACH2 GATA2 MEF2D CPSF4 ARNT2 NFYA KLF17 HSF1 MNT NPAS2 DIDO1 E2F2 CREM PHC1 RIF1 KLF10 NKX2-1 TRIM28 ARID2 ZFHX3 PBX3	1.62e-08	808	224	22	20412781
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	IRF2BP2 EPPK1 CKAP5 TNRC18 SBF1 AHNAK DENND6B ITSN1 NSD1 DALRD3 TRIM28 CNOT1 ALPK2 AHNAK2	3.98e-08	332	224	14	37433992
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	MYADM FAM120B MAP4 MAP6 CKAP5 ARHGEF17 USP31 PHLDB1 SBF1 SNAP91 ARHGAP44 KMT2A FH BSN TRAPPC9 TOM1L2 PRR36 SYNE1 PCLO ITSN1 DPYSL4 PABPC1 SF3B1 SHANK2 SEC24C TRIM28 SIPA1L1 NCAN CNOT1	5.30e-08	1431	224	29	37142655
Pubmed	The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.	EPPK1 RAD54L2 RREB1 ARHGAP22 TCERG1 BANP CPVL KIFC1 CREB1 CREB5 RIF1 SF3B1 NUP155 SEC24C ZFHX4 TRIM28 ZFHX3 PBX3	5.41e-08	583	224	18	29844126
Pubmed	Interaction network of human early embryonic transcription factors.	TRERF1 NCOA6 HIVEP2 KMT2B MAML1 RAD54L2 RREB1 TNRC18 KMT2A CPVL ZFHX4 EGR2 ARID2 ZFHX3	7.92e-08	351	224	14	38297188
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TRERF1 MAP6 CKAP5 SIRPG SBF1 SNAP91 ARHGAP44 BSN PRR36 SYNE1 ITSN1 NSD1 DPYSL4 DIDO1 PABPC1 SF3B1 SHANK2 SEC24C TRIM28 SIPA1L1 NCAN CNOT1 AFF4	8.13e-08	963	224	23	28671696
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	MYADM KMT2B MAP4 NACA CKAP5 MAML1 CPSF4 SBF1 TCERG1 FBXO28 KMT2A CHD6 KIFC1 UBQLN1 SYNE1 RALGAPB NSD1 DIDO1 PHC2 RIF1 GORASP2 SHANK2 PLEKHG3 ARID2 SLC25A13 SIPA1L1 MED25 ZFHX3 AFF4	1.37e-07	1497	224	29	31527615
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	ZBTB16 HIVEP2 BACH2 GATA2 MEF2D CPSF4 ARNT2 KMT2A KLF17 MNT DIDO1 E2F2 CREM PHC1 NKX2-1 TRIM28 ZFHX3 PBX3 RFPL2	2.05e-07	709	224	19	22988430
Pubmed	Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset.	BTN3A3 BTN3A2 BTN3A1	2.64e-07	3	224	3	22767497
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	EPPK1 MAP4 CKAP5 RAD54L2 RREB1 TCERG1 AHNAK DIDO1 RIF1 SF3B1 TRIM28 ARID2 AHNAK2	2.87e-07	332	224	13	32786267
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	FAM120B MAP6 CPSF4 SBF1 TCERG1 CHD6 DOCK6 SEC23B NPAS2 PTBP3 SYNE1 CECR2 DPYSL4 DIDO1 PHC2 CCNT2 SF3B1 SEC24C TRIM28 ARID2 SLC25A13 CNOT1 AFF4	6.24e-07	1082	224	23	38697112
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	TRERF1 IRF2BP2 NCOA6 KMT2B MAP4 CKAP5 MAML1 RAD54L2 RREB1 MEF2D TNRC18 TCERG1 KMT2A BAG6 MNT KIFC1 UBQLN1 DIDO1 CREB1 PABPC1 CCNT2 ARID2 CNOT1	8.67e-07	1103	224	23	34189442
Pubmed	A High-Density Map for Navigating the Human Polycomb Complexome.	NCOA6 HIVEP2 KMT2B RREB1 FBXO22 FBXO28 KMT2A CPVL MNT DIDO1 E2F2 PHC1 PHC2 TRIM28 CSTA	9.07e-07	495	224	15	27705803
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	EPPK1 GALNT2 MAP4 NACA CKAP5 CPSF4 PHLDB1 SMPDL3B AARS2 AHNAK BAG6 KIFC1 SYNE1 PABPC1 RIF1 SF3B1 NUP155 SEC24C TRIM28 PLEKHG3 SLC25A13 CNOT1	9.32e-07	1024	224	22	24711643
Pubmed	Primate-specific BTN3A2 protects against SARS-CoV-2 infection by interacting with and reducing ACE2.	BTN3A3 BTN3A2 BTN3A1	1.05e-06	4	224	3	39142074
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	EPPK1 ACADS MAP4 NACA KMT2A BSN COL27A1 SIPA1L1 POLQ CNOT1	1.11e-06	208	224	10	33230847
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	MYADM CIART BACH2 MTSS1 ARMCX2 FREM2 TNRC18 AARS2 FBXO28 BANP FGF4 MNT PTBP3 OTUD5 NSD1 DIDO1 CREM DALRD3 PHC1 PLEKHG3 ARID2 NCAN FUT1 PBX3	1.28e-06	1215	224	24	15146197
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	EPPK1 MAP4 CKAP5 SBF1 AHNAK KMT2A FH SEC23B NSD1 DIDO1 PABPC1 RIF1 SF3B1 NUP155 SEC24C SLC25A13 CNOT1	1.36e-06	653	224	17	22586326
Pubmed	Hypertonicity-responsive ubiquitin ligase RNF183 promotes Na, K-ATPase lysosomal degradation through ubiquitination of its β1 subunit.	PDXDC1 MAP4 NACA CKAP5 STARD9 AHNAK SEC23B TOM1L2 ITSN1 FCHO2 GORASP2 IPO9 NUP155 SLC25A13	1.51e-06	449	224	14	31732153
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	TRERF1 IRF2BP2 NCOA6 MAML1 MEF2D CPSF4 TNRC18 KMT2A KIFC1 CREB1 AFF4	1.52e-06	268	224	11	33640491
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	NCOA6 NACA MTSS1 MAML1 SBF1 BSN CARNS1 DOCK6 CECR2 DIDO1 FNDC3A NUP155 SETBP1 LRP4 CNOT1	2.06e-06	529	224	15	14621295
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	NCOA6 GBF1 CEP68 PHLDB1 CHD6 SYNE1 RALGAPB FNDC3A SIPA1L1 SETBP1	2.25e-06	225	224	10	12168954
Pubmed	Heteromeric interactions regulate butyrophilin (BTN) and BTN-like molecules governing γδ T cell biology.	BTN3A3 BTN3A2 BTN3A1	2.61e-06	5	224	3	29339503
Pubmed	Embryonic Poly(A)-Binding Protein (EPAB) Is Required for Granulosa Cell EGF Signaling and Cumulus Expansion in Female Mice.	PABPC1 EGFR PABPC1L	2.61e-06	5	224	3	26492470
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CLSTN3 CKAP5 ARHGEF17 USP31 PHLDB1 STARD9 FBXO28 CHD6 SYNE1 RALGAPB AHCYL2 SEC24C SIPA1L1	2.78e-06	407	224	13	12693553
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	MEF2D AARS2 STARD9 BANP UNKL BSN HSF1 SYNE1 RIF1 SF3B1	3.08e-06	233	224	10	37704626
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	RAB19 MYADM GBF1 MAP4 NACA DAB1 CPSF4 SULT1A1 TCERG1 STARD9 AHNAK KMT2A PTBP3 DIDO1 OAS3 PATL1 PABPC1 PHC2 RIF1 IPO9 SF3B1 SEC24C CSTA CNOT1 AFF4	3.14e-06	1371	224	25	36244648
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	ALLC GBF1 CKAP5 MAML1 MEF2D AARS2 TCERG1 BANP NFYA MNT FOXF2 CREB1 CREM CREB5 RIF1 SF3B1 ZFHX4 CSTA PBX3	3.40e-06	857	224	19	25609649
Pubmed	A human MAP kinase interactome.	HDAC9 HIVEP2 MEF2D TCERG1 NFYA CHD6 TOM1L2 SYNE1 ITSN1 CREB1 RIF1 SF3B1 TRIM28 ARID2	3.78e-06	486	224	14	20936779
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	PDXDC1 IRF2BP2 MAP4 CKAP5 VPS16 AARS2 TCERG1 CPVL BAG6 PTBP3 COG2 IPO9 NUP155 SLC25A13 CNOT1	4.10e-06	560	224	15	35241646
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	MAML1 TYSND1 MEF2D CPSF4 PHLDB1 AGFG2 DOCK6 SEC23B WWC1 TOM1L2 AHCYL2 PATL1 FCHO2 PABPC1 RFWD3 GORASP2 SHANK2 SEC24C PABPC1L CNOT1 CRTC2	4.24e-06	1038	224	21	26673895
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	GALNT2 NACA RAD54L2 FREM2 SBF1 TCERG1 KMT2A SEC23B KIFC1 RALGAPB DIDO1 PATL1 RFWD3 NUP155 CRTC2 HR	5.68e-06	650	224	16	38777146
Pubmed	Mammalian polycomb-mediated repression of Hox genes requires the essential spliceosomal protein Sf3b1.	KMT2A PHC1 PHC2 SF3B1	6.02e-06	19	224	4	15741318
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	EPPK1 MAP4 NACA CKAP5 AHNAK KIFC1 DIDO1 SF3B1 EGFR AHNAK2	7.06e-06	256	224	10	33397691
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	ZNF280A IRF2BP2 MAP4 RAD54L2 MEF2D TCERG1 AHNAK HSF1 SF3B1 KLF10 TRIM28 CSTA AHNAK2	7.10e-06	444	224	13	34795231
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	IRF2BP2 GALNT2 NACA NOD2 AARS2 AHNAK KMT2A ATP13A3 CPVL BAG6 TRAPPC9 COG2 OAS3 FCHO2 IPO9 SF3B1 NUP155 TRIM28 PLEKHG3 SLC25A13 SIPA1L1 CSTA LRP4 CNOT1 AHNAK2	7.33e-06	1440	224	25	30833792
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	RAD54L2 DCC TNRC18 CLCN5 SNAP91 UMODL1 STARD9 AHNAK KMT2A CHD6 BSN PTBP3 CACNA1C SYNE1 PCLO ITSN1 AHCYL2 PABPC1 SPATC1 SF3B1 SHANK2 SLC25A13 PABPC1L MYOM2 POLQ	7.51e-06	1442	224	25	35575683
Pubmed	Recruitment of the Mammalian Histone-modifying EMSY Complex to Target Genes Is Regulated by ZNF131.	KMT2B TNRC18 AHNAK BANP KMT2A PWWP2B ZNF335	7.59e-06	110	224	7	26841866
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	EPPK1 NACA ARHGEF17 ARHGAP22 CPSF4 TCERG1 FBXO28 AHNAK ARHGAP44 KMT2A DOCK6 CPVL PRR36 ITSN1 AHCYL2 CCNT2 RIF1 PLEKHG3 CSTA	8.73e-06	916	224	19	32203420
Pubmed	Assembly, verification, and initial annotation of the NIA mouse 7.4K cDNA clone set.	RAB19 DCC TIGD3 RALGAPB CREM SF3B1 EGFR CRTC2	8.77e-06	157	224	8	12466305
Pubmed	The cluster of BTN genes in the extended major histocompatibility complex.	BTN3A3 BTN3A2 BTN3A1	9.05e-06	7	224	3	11170752
Pubmed	Phosphorylation of BACH1 switches its function from transcription factor to mitotic chromosome regulator and promotes its interaction with HMMR.	MAP4 BACH2 CKAP5 FBXO22 ARID2 CNOT1	9.28e-06	75	224	6	29459360
Pubmed	The N6-methyladenosine-mediated lncRNA WEE2-AS1 promotes glioblastoma progression by stabilizing RPN2.	IRF2BP2 FAM120B GBF1 GALNT2 CKAP5 DPYSL4 DIDO1 EGFR EGR2 SLC25A13 CNOT1	9.55e-06	325	224	11	36168628
Pubmed	Impact of cytosine methylation on DNA binding specificities of human transcription factors.	BACH2 GATA2 MEF2D CPSF4 ARNT2 KLF17 HSF1 NPAS2 E2F2 CREB1 CREM CREB5 KLF10 EGR2	1.35e-05	544	224	14	28473536
Pubmed	The DNA sequence and analysis of human chromosome 6.	TRERF1 GABRR1 HIVEP2 MAN1A1 BACH2 BTN3A3 EFHC1 AARS2 SNAP91 NFYA BAG6 KIFC1 SYNE1 BTN3A2 BTN3A1	1.42e-05	622	224	15	14574404
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	NCOA6 MAP4 RREB1 MEF2D TCERG1 SNAP91 AHNAK KMT2A KIFC1 NSD1 DIDO1 CREB1 PABPC1 CREM RIF1 SF3B1 TRIM28 ARID2 AFF4	1.54e-05	954	224	19	36373674
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	MAP4 SNAP91 PRRT3 BSN TOM1L2 CACNA1C PCLO ITSN1 AHCYL2 SHANK2 SIPA1L1	1.75e-05	347	224	11	17114649
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	PDXDC1 GBF1 CKAP5 AARS2 TCERG1 BAG6 PABPC1 RIF1 IPO9 SF3B1 NUP155 SEC24C TRIM28 SLC25A13 CNOT1	1.91e-05	638	224	15	33239621
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	HDAC9 GBF1 ARMCX2 CEP68 TNRC18 AARS2 DDHD2 TRAPPC9 COL27A1 IPO9 PLEKHG3 ARID2 POM121B	2.14e-05	493	224	13	15368895
Pubmed	NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function.	MAML1 TRAPPC9 PTBP3 RIF1 TRIM28 MED25 CNOT1	2.15e-05	129	224	7	23022380
Pubmed	Proteolysis of MLL family proteins is essential for taspase1-orchestrated cell cycle progression.	KMT2B KMT2A E2F2	2.15e-05	9	224	3	16951254
Pubmed	Molecular characterization and mapping of murine genes encoding three members of the stefin family of cysteine proteinase inhibitors.	SULT1A2 SULT1A1 CSTA	2.15e-05	9	224	3	8468045
Pubmed	TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex.	MAP4 CKAP5 BAG6 PABPC1 IPO9 SF3B1 TRIM28 SLC25A13	2.27e-05	179	224	8	36261009
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	FAM120B MAP4 NACA CKAP5 VPS16 PHLDB1 FBXO22 SBF1 TCERG1 AHNAK BAG6 OAS3 PABPC1 RIF1 IPO9 SF3B1 NUP155 SEC24C TRIM28 PLEKHG3 SLC25A13 CSTA AHNAK2	2.42e-05	1353	224	23	29467282
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	HDAC9 CLSTN3 HIVEP2 GALNT2 CKAP5 RAD54L2 TCERG1 DENND6B CHD6 COG2 UBQLN1 SYNE1 ITSN1 DALRD3 GORASP2 SF3B1 GUK1 SIPA1L1 LRP4 PBX3 QTRT1 AFF4	3.29e-05	1285	224	22	35914814
Pubmed	High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface.	FAM120B MDM1 CKAP5 MAML1 ULBP3 FREM2 PVR DENND6B USP43 EGFR	3.37e-05	307	224	10	37499664
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	NCOA6 KMT2B GATA2 CKAP5 RREB1 CPSF4 TCERG1 FBXO28 AHNAK BANP KMT2A CHD6 MNT NSD1 DIDO1 CREB1 CREM RFWD3 PHC2 RIF1 SF3B1 TRIM28	3.65e-05	1294	224	22	30804502
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	IRF2BP2 MAP4 NACA CKAP5 TCERG1 AHNAK KMT2A DPYSL4 DIDO1 PABPC1 RIF1 GORASP2 SF3B1 FAM193A TRIM28 ARID2 AFF4 AHNAK2	3.96e-05	934	224	18	33916271
Pubmed	Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription.	NCOA6 KMT2B CNOT1 AFF4 AHNAK2	4.00e-05	59	224	5	28813667
Pubmed	Dynamic interactions between L-type voltage-sensitive calcium channel Cav1.2 subunits and ahnak in osteoblastic cells.	AHNAK CACNA1C	4.13e-05	2	224	2	19261907
Pubmed	Ron tyrosine kinase receptor synergises with EGFR to confer adverse features in head and neck squamous cell carcinoma.	MST1R EGFR	4.13e-05	2	224	2	23799848
Pubmed	Bassoon and Piccolo maintain synapse integrity by regulating protein ubiquitination and degradation.	BSN PCLO	4.13e-05	2	224	2	23403927
Pubmed	Characterisation of the global transcriptional response to heat shock and the impact of individual genetic variation.	HSF1 UBQLN1	4.13e-05	2	224	2	27553423
Pubmed	The transcriptional co-activator NCOA6 promotes estrogen-induced GREB1 transcription by recruiting ERα and enhancing enhancer-promoter interactions.	NCOA6 GREB1	4.13e-05	2	224	2	31744881
Pubmed	Increased hippocampal neurogenesis and accelerated response to antidepressants in mice with specific deletion of CREB in the hippocampus: role of cAMP response-element modulator τ.	CREB1 CREM	4.13e-05	2	224	2	23966689
Pubmed	Role of Bassoon and Piccolo in Assembly and Molecular Organization of the Active Zone.	BSN PCLO	4.13e-05	2	224	2	26793095
Pubmed	Genotype distributions and allele frequencies of possible major depressive disorder-associated single nucleotide polymorphisms, cyclic adenosine monophosphate response element binding protein 1 rs4675690 and Piccolo rs2522833, in a Japanese population.	PCLO CREB1	4.13e-05	2	224	2	22293360
Pubmed	The minimal promoter region of the dense-core vesicle protein IA-2: transcriptional regulation by CREB.	PTPRN CREB1	4.13e-05	2	224	2	25528004
Pubmed	Piccolo mediates EGFR signaling and acts as a prognostic biomarker in esophageal squamous cell carcinoma.	PCLO EGFR	4.13e-05	2	224	2	28263981
Pubmed	Cyclic adenosine 5'-monophosphate response element binding protein plays a central role in mediating proliferation and differentiation downstream of the pre-TCR complex in developing thymocytes.	CREB1 CREM	4.13e-05	2	224	2	15265911
Pubmed	Sulfation pharmacogenetics: SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese and African-American subjects.	SULT1A2 SULT1A1	4.13e-05	2	224	2	11207031
Pubmed	Active zone density is conserved during synaptic growth but impaired in aged mice.	BSN PCLO	4.13e-05	2	224	2	21935939
Pubmed	NF-Y behaves as a bifunctional transcription factor that can stimulate or repress the FGF-4 promoter in an enhancer-dependent manner.	NFYA FGF4	4.13e-05	2	224	2	16128003
Pubmed	The mouse ZFH-4 protein contains four homeodomains and twenty-two zinc fingers.	ZFHX4 ZFHX3	4.13e-05	2	224	2	10873665
Pubmed	Hepatic noradrenergic innervation acts via CREB/CRTC2 to activate gluconeogenesis during cold.	CREB1 CRTC2	4.13e-05	2	224	2	38878857
Pubmed	Ahnak is critical for cardiac Ca(V)1.2 calcium channel function and its beta-adrenergic regulation.	AHNAK CACNA1C	4.13e-05	2	224	2	16319140
Pubmed	Impaired expression of the inducible cAMP early repressor accounts for sustained adipose CREB activity in obesity.	CREB1 CREM	4.13e-05	2	224	2	21998402
Pubmed	Human CREM gene: evolutionary conservation, chromosomal localization, and inducibility of the transcript.	CREB1 CREM	4.13e-05	2	224	2	7916662
Pubmed	Cyclic AMP response element binding protein CREB and modulator protein CREM are products of distinct genes.	CREB1 CREM	4.13e-05	2	224	2	1461747
Pubmed	Epidermal growth factor receptor (EGFR) signaling promotes proliferation and survival in osteoprogenitors by increasing early growth response 2 (EGR2) expression.	EGFR EGR2	4.13e-05	2	224	2	23720781
Pubmed	Cross-talk between the receptor tyrosine kinases Ron and epidermal growth factor receptor.	MST1R EGFR	4.13e-05	2	224	2	14499632
Pubmed	L-type CaV1.2 deletion in the cochlea but not in the brainstem reduces noise vulnerability: implication for CaV1.2-mediated control of cochlear BDNF expression.	CACNA1C EGR2	4.13e-05	2	224	2	23950737
Pubmed	cAMP response element-binding protein regulates differentiation and survival of newborn neurons in the olfactory bulb.	CREB1 CREM	4.13e-05	2	224	2	16267218
Pubmed	The relationship between TTF-1 expression and EGFR mutations in lung adenocarcinomas.	EGFR NKX2-1	4.13e-05	2	224	2	24743427
Pubmed	Mechanism of CREB recognition and coactivation by the CREB-regulated transcriptional coactivator CRTC2.	CREB1 CRTC2	4.13e-05	2	224	2	23213254
Pubmed	Mechanism of repression of the inhibin alpha-subunit gene by inducible 3',5'-cyclic adenosine monophosphate early repressor.	INHA CREM	4.13e-05	2	224	2	16269517
Pubmed	Primary structures and properties of two related forms of aryl sulfotransferases in human liver.	SULT1A2 SULT1A1	4.13e-05	2	224	2	7581483
Pubmed	NF-Y binds to the CCAAT box motif of the FGF-4 gene and promotes FGF-4 expression in embryonal carcinoma cells.	NFYA FGF4	4.13e-05	2	224	2	9322240
Pubmed	AHNAK1 and AHNAK2 are costameric proteins: AHNAK1 affects transverse skeletal muscle fiber stiffness.	AHNAK AHNAK2	4.13e-05	2	224	2	20833135
Pubmed	Localisation of aryl sulfotransferase expression in human tissues using hybridisation histochemistry and immunohistochemistry.	SULT1A2 SULT1A1	4.13e-05	2	224	2	9566757
Pubmed	Structural Insights into the CRTC2-CREB Complex Assembly on CRE.	CREB1 CRTC2	4.13e-05	2	224	2	29733854
Pubmed	Dual-color STED microscopy reveals a sandwich structure of Bassoon and Piccolo in active zones of adult and aged mice.	BSN PCLO	4.13e-05	2	224	2	27321892
Pubmed	H3K36 methyltransferase NSD1 is essential for normal B1 and B2 cell development and germinal center formation.	NSD1 CD79A	4.13e-05	2	224	2	36532012
Interaction	TOP3B interactions	NCOA6 EPPK1 HIVEP2 GBF1 KMT2B GATA2 MAML1 NOD2 PHLDB1 TNRC18 FBXO22 SBF1 AHNAK ARHGAP44 BANP TIGD3 UNKL DOCK6 CPVL TRAPPC9 SEC23B COL4A5 POC1A MYOM3 NSD1 PATL1 PABPC1 BTN3A2 PHC2 MST1R GORASP2 PWWP2B SHANK2 KLF10 TRIM28 SLC25A13 ZNF335 LRP4 FUT1 CNOT1 AHNAK2 HR	7.37e-09	1470	220	42	int:TOP3B
Interaction	EGR2 interactions	TRERF1 NCOA6 HIVEP2 MAML1 RAD54L2 RREB1 TNRC18 KMT2A ZFHX4 EGR2 ARID2 ZFHX3	4.07e-07	171	220	12	int:EGR2
Interaction	TLE3 interactions	TRERF1 IRF2BP2 HIVEP2 GATA2 MAML1 RAD54L2 TLX1 TNRC18 AGFG2 KMT2A CHD6 CECR2 FAM193A EGR2 ARID2 ZFHX3 CRTC2	8.86e-07	376	220	17	int:TLE3
Interaction	AR interactions	TRERF1 IRF2BP2 NCOA6 EPPK1 ZBTB16 MAML1 RAD54L2 TYSND1 DCC RREB1 ACY1 MEF2D CPSF4 TNRC18 KMT2A BAG6 SEC23B KIFC1 TOM1L2 NSD1 DIDO1 CREB1 PABPC1 SF3B1 EGFR TRIM28 ARID2 ZFHX3 AFF4	1.34e-06	992	220	29	int:AR
Interaction	FEV interactions	NCOA6 KMT2B MAML1 RAD54L2 RREB1 KMT2A CHD6 KIFC1 CREB1 ZFHX4 ARID2 ZFHX3	2.50e-06	203	220	12	int:FEV
Interaction	CTBP1 interactions	HDAC9 MAML1 RREB1 CEP68 ARNT2 KMT2A UNKL BAG6 SEC23B PCLO CREB5 IPO9 KLF10 SEC24C EGFR NKX2-1	1.07e-05	406	220	16	int:CTBP1
Interaction	CIC interactions	EPPK1 GATA2 RAD54L2 RREB1 TLX1 ARHGAP22 TCERG1 BANP CPVL KIFC1 CREB1 CREB5 RIF1 SF3B1 NUP155 SEC24C ZFHX4 EGFR TRIM28 ZFHX3 PBX3	1.64e-05	673	220	21	int:CIC
Interaction	MAPKAPK2 interactions	ACY1 CPSF4 HSF1 DIDO1 CREB1 PABPC1 PHC1 PHC2 TRIM28	1.68e-05	134	220	9	int:MAPKAPK2
Interaction	ATF2 interactions	NCOA6 BACH2 NACA ARHGAP22 AHNAK BANP NFYA FH CREB1 CREB5 NKX2-1 SLC25A13	1.84e-05	247	220	12	int:ATF2
Interaction	MEX3A interactions	IRF2BP2 EPPK1 CKAP5 TNRC18 SBF1 AHNAK DENND6B ITSN1 NSD1 PABPC1 DALRD3 TRIM28 CNOT1 ALPK2 AHNAK2	2.25e-05	384	220	15	int:MEX3A
Interaction	TEAD1 interactions	IRF2BP2 RREB1 MEF2D ARNT2 KIFC1 ZFHX4 EGFR NKX2-1 ARID2 ZFHX3	2.45e-05	176	220	10	int:TEAD1
Interaction	SOX7 interactions	BACH2 MAML1 RREB1 TNRC18 CECR2 ZFHX4 ARID2	3.19e-05	82	220	7	int:SOX7
Interaction	RARA interactions	NCOA6 ZBTB16 GATA2 NPAS2 UBQLN1 NSD1 PABPC1 NKX2-1 MED25 CNOT1 HR	3.58e-05	223	220	11	int:RARA
Interaction	CCDC8 interactions	EPPK1 GALNT2 MAP4 NACA CKAP5 CPSF4 PHLDB1 SMPDL3B AARS2 AHNAK KIFC1 PABPC1 DALRD3 SF3B1 NUP155 TRIM28 PLEKHG3 SLC25A13 CNOT1 AFF4	3.64e-05	656	220	20	int:CCDC8
Interaction	SULT1A2 interactions	SULT1A2 SULT1A1 TRAPPC9 NUP155	4.71e-05	19	220	4	int:SULT1A2
Interaction	JUN interactions	HDAC9 NCOA6 BACH2 NACA GATA2 MEF2D ARHGAP22 CEP68 BANP NFYA NSD1 DIDO1 AHCYL2 CREB1 CREB5 EGFR	6.28e-05	470	220	16	int:JUN
Interaction	YWHAH interactions	NCOA6 EPPK1 HIVEP2 GBF1 CKAP5 ARHGEF17 MEF2D USP31 PHLDB1 AARS2 SBF1 TCERG1 STARD9 AHNAK KMT2A DOCK6 TRAPPC9 SEC23B WWC1 RALGAPB USP43 MST1R IPO9 PLEKHG3 SIPA1L1 CRTC2 AHNAK2	7.28e-05	1102	220	27	int:YWHAH
Interaction	PHLPP1 interactions	EPPK1 MAP4 NACA CKAP5 FBXO22 AHNAK KIFC1 DIDO1 FCHO2 SF3B1 EGFR RFPL2 AHNAK2	8.01e-05	333	220	13	int:PHLPP1
Interaction	CSTF2 interactions	POU6F2 MAP4 ARHGAP22 CPSF4 FBXO22 BAG6 UBQLN1 PABPC1 TRIM28	8.59e-05	165	220	9	int:CSTF2
Interaction	ASF1A interactions	IRF2BP2 NCOA6 KMT2B RREB1 MEF2D KMT2A CHD6 NSD1 RIF1 ARID2 CSTA	9.66e-05	249	220	11	int:ASF1A
Interaction	GDF10 interactions	BANP LRP4 CD79A	1.03e-04	9	220	3	int:GDF10
Interaction	RXRA interactions	NCOA6 ZBTB16 GATA2 RAD54L2 MEF2D NPAS2 NSD1 MED25 CNOT1	1.03e-04	169	220	9	int:RXRA
Interaction	KMT2D interactions	NCOA6 KMT2B GATA2 MEF2D TLX1 KMT2A E2F2 NUP155 EGR2	1.03e-04	169	220	9	int:KMT2D
Interaction	CREBBP interactions	TRERF1 NCOA6 HIVEP2 GATA2 MAML1 TLX1 CPSF4 ARNT2 NFYA KMT2A HSF1 NPAS2 CREB1 CREM EGR2 NKX2-1 TRIM28 MED25	1.08e-04	599	220	18	int:CREBBP
Interaction	KMT2C interactions	NCOA6 KMT2B GATA2 TLX1 FBXO22 KMT2A PABPC1 EGR2	1.14e-04	134	220	8	int:KMT2C
Interaction	TRIM11 interactions	PDXDC1 BTN3A3 BANP HSF1 BAG6 PTBP3 CREB1 TRIM28 PABPC1L	1.23e-04	173	220	9	int:TRIM11
Interaction	KCTD13 interactions	MYADM FAM120B MAP4 MAP6 CKAP5 ARHGEF17 USP31 PHLDB1 SBF1 SNAP91 ARHGAP44 KMT2A FH BSN TRAPPC9 TOM1L2 PRR36 SYNE1 PCLO ITSN1 DPYSL4 AHCYL2 PABPC1 GORASP2 SF3B1 SHANK2 SEC24C TRIM28 SIPA1L1 NCAN CNOT1	1.23e-04	1394	220	31	int:KCTD13
Interaction	SP7 interactions	TRERF1 IRF2BP2 NCOA6 KMT2B MAML1 MEF2D CPSF4 TCERG1 CPVL ZFHX4 ARID2 SLC25A13	1.36e-04	304	220	12	int:SP7
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	TSHZ2 ZFHX4 ZFHX3	2.46e-04	15	152	3	529
GeneFamily	Butyrophilins\|V-set domain containing\|C2-set domain containing	BTN3A3 BTN3A2 BTN3A1	2.46e-04	15	152	3	458
GeneFamily	PDZ domain containing	AHNAK PCLO GORASP2 SHANK2 SIPA1L1 SDCBP2 AHNAK2	3.02e-04	152	152	7	1220
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	DCC HMCN2 ALPK3 MYOM3 MYOM2 MDGA1 ALPK2	4.28e-04	161	152	7	593
GeneFamily	Adenosine receptors\|V-set domain containing	SIRPG BTN3A3 PVR BTN3A2 BTN3A1 NCAN CD79A	4.61e-04	163	152	7	590
GeneFamily	Ubiquilin family	UBQLN1 UBQLN3	6.91e-04	5	152	2	783
GeneFamily	Basic leucine zipper proteins	BACH2 CREB1 CREM CREB5	7.58e-04	49	152	4	506
GeneFamily	PHD finger proteins	KMT2B KMT2A NSD1 DIDO1 TRIM28	9.73e-04	90	152	5	88
GeneFamily	Immunoglobulin like domain containing	DCC HMCN2 PVR ALPK3 MYOM3 MYOM2 MDGA1	1.25e-03	193	152	7	594
GeneFamily	Fibronectin type III domain containing\|I-set domain containing\|Myosin binding proteins	MYOM3 MYOM2	1.90e-03	8	152	2	658
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	KMT2B KMT2A NSD1	2.88e-03	34	152	3	487
GeneFamily	Zinc fingers CXXC-type	KMT2B KMT2A	4.39e-03	12	152	2	136
GeneFamily	Fucosyltransferases\|Blood group antigens	FUT1 FUT5	5.15e-03	13	152	2	434
GeneFamily	Sulfotransferases, cytosolic	SULT1A2 SULT1A1	5.98e-03	14	152	2	762
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	LILRB2 ITGA2B SIRPG PVR MPL LILRA2 BTN3A1 MST1R CD79A	6.18e-03	394	152	9	471
GeneFamily	Sterile alpha motif domain containing	DDHD2 PHC1 PHC2 SHANK2	6.48e-03	88	152	4	760
GeneFamily	Collagens	COL4A5 COL15A1 COL27A1	6.79e-03	46	152	3	490
GeneFamily	Zinc fingers\|Zinc fingers PARP-type\|Poly(ADP-ribose) polymerases	BSN PCLO	6.86e-03	15	152	2	26
Coexpression	GSE15767_MED_VS_SCS_MAC_LN_DN	RAB19 HIVEP2 MAP4 RAD54L2 ARNT2 DENND6B CARNS1 NPAS2 SEC24C SIPA1L1 PABPC1L AFF4	1.52e-07	199	223	12	M3585
Coexpression	PEREZ_TP53_TARGETS	EPPK1 MAN1A1 MAP6 GATA2 MAML1 BBS1 TYSND1 ARHGEF17 SMPDL3B UMODL1 ARHGAP44 ARNT2 PRRT3 UNKL CARNS1 FOXF2 COL15A1 COL27A1 DPYSL4 DIDO1 FCHO2 VWCE ARID2 GREB1 FUT1 AHNAK2 HR	4.29e-06	1201	223	27	M4391
Coexpression	GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_UP	HIVEP2 MTSS1 BTN3A3 CPSF4 SBF1 FH PMS2P5 DIDO1 BTN3A1 SEC24C	5.18e-06	188	223	10	M5648
Coexpression	FIGUEROA_AML_METHYLATION_CLUSTER_3_DN	MAML1 PHLDB1 AHNAK MED25 AHNAK2	2.20e-05	40	223	5	M2169
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN	PDXDC1 MYADM VPS16 RAD54L2 MEF2D SULT1A2 SULT1A1 SBF1 DENND6B CARNS1 MNT DIDO1 CREB1 PABPC1 BTN3A1 SF3B1 KLF10 SEC24C MED25 ZFHX3 PABPC1L	3.38e-05	905	223	21	M40865
Coexpression	GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_UP	MAN1A1 GPAA1 GALNT2 TLX1 SMPDL3B DENND6B SEC23B GORASP2 HR	4.18e-05	192	223	9	M3176
Coexpression	GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_UP	IRF2BP2 MTSS1 BBS1 BTN3A3 EFHC1 UNKL NSD1 FCHO2 CSTA	4.53e-05	194	223	9	M7313
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	HIVEP2 GBF1 CKAP5 ARNT2 ATP13A3 MNT WWC1 ITSN1 FNDC3A CREB1 CREB5 TDRD7 RIF1 FAM193A KLF10 EGFR SLC25A13 SIPA1L1 ZFHX3 PBX3	4.75e-05	856	223	20	M4500
Coexpression	GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_DN	MEF2D CEP68 SMPDL3B PTPRN DDHD2 SYNE1 CREB1 SEC24C PLEKHG3	4.91e-05	196	223	9	M5504
Coexpression	GSE23321_CENTRAL_MEMORY_VS_NAIVE_CD8_TCELL_DN	ARHGAP22 PTPRN AGFG2 CPVL COL4A5 CACNA1C COL15A1 GPRC5B HR	5.11e-05	197	223	9	M8431
Coexpression	GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN	HIVEP2 RREB1 BANP ATP13A3 PATL1 PHC1 KLF10 GUK1 CRTC2	5.52e-05	199	223	9	M5348
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	HIVEP2 MAML1 NFYA ATP13A3 MNT WWC1 NPAS2 DIDO1 FNDC3A PHC2 RIF1	5.69e-05	300	223	11	M8702
Coexpression	GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP	BACH2 MAML1 BTN3A3 BANP CCNT2 KLF10 EGR2 MYOM2 SLC16A10	5.74e-05	200	223	9	M8030
Coexpression	GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_DN	ITGA2B ARMCX2 CEP68 FBXO22 AHNAK CARNS1 MNT COL27A1 SLC17A5	5.74e-05	200	223	9	M6556
Coexpression	GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_UP	BACH2 MTSS1 ARHGEF17 MEF2D COL4A5 PHC1 FAM193A EGR2 GREB1	5.74e-05	200	223	9	M9203
Coexpression	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP	HIVEP2 ARHGEF17 SULT1A1 SNAP91 PTPRN ARNT2 DDHD2 BSN BAG6 MNT PRR36 CCK FAM193A NPTXR TRIM28 NCAN GPRC5B AHNAK2	8.91e-05	755	223	18	M2105
Coexpression	LAKE_ADULT_KIDNEY_C28_INTERSTITIUM	ZBTB16 TSHZ2 CACNA1C SYNE1 ITSN1 SETBP1	9.46e-05	86	223	6	M39247
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	GALNT2 TSHZ2 BACH2 PHLDB1 NPAS2 CACNA1C COL27A1 CREB5 LRP4 GREB1 PBX3	2.20e-09	182	223	11	ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
ToppCell	LA-02._Fibroblast_II\|LA / Chamber and Cluster_Paper	PDXDC1 ZBTB16 TSHZ2 BACH2 PHLDB1 COL15A1 CREB5 EGFR SLC25A13 SETBP1 ZFHX3	4.31e-09	194	223	11	234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RREB1 PHLDB1 CARNS1 COL4A5 CECR2 CREB5 ZFHX4 LRP4 ZFHX3 GPRC5B	4.25e-08	189	223	10	42ab4cc5fbf8580841f31889446fe4499df1a464
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	ZBTB16 MAN1A1 TSHZ2 PHLDB1 STARD9 PTBP3 COL15A1 EGFR SLC25A13 ZFHX3	4.69e-08	191	223	10	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	Adult-Mesenchymal-myofibroblast_cell\|Adult / Lineage, Cell type, age group and donor	INHA TSHZ2 BACH2 PHLDB1 KLHL33 DOCK6 CACNA1C MYOM3 POLQ	1.74e-07	167	223	9	d584a8548a5317bd9686b3be8246ae6ed568796b
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 POU6F2 TSHZ2 MTSS1 IRAG1 ARHGEF17 SULT1A2 SYNE1 TRMO	2.72e-07	176	223	9	a4d269075aa0efc46fa251b379f334e50c69391d
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 POU6F2 TSHZ2 MTSS1 IRAG1 ARHGEF17 SULT1A2 SYNE1 TRMO	2.72e-07	176	223	9	cc6f65a7d2c622841c9d1ab3755586039d4ccc4d
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRERF1 POU6F2 TSHZ2 MTSS1 IRAG1 ARHGEF17 SULT1A2 SYNE1 TRMO	2.72e-07	176	223	9	e9152defb4fd41267fb33c42c01fd0c683280783
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D122\|Adult / Lineage, Cell type, age group and donor	ZBTB16 TSHZ2 BACH2 PHLDB1 KLHL33 COL15A1 SETBP1 GREB1 GASK1A	3.96e-07	184	223	9	2b7e6f91e11c228f0521e099886867d9e998e78d
ToppCell	wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	QRICH2 FREM2 CLCN5 CECR2 COL27A1 PWWP2B ZNF335 GREB1 SLC16A10	4.15e-07	185	223	9	636505a3d96f75d951ab42bcf8af6ae07abc732d
ToppCell	Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PHLDB1 CARNS1 COL4A5 CECR2 CREB5 ZFHX4 PLEKHG3 LRP4 GPRC5B	4.54e-07	187	223	9	97e520705491c8f52a32025311a9fa7b9176979a
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TSHZ2 BACH2 PHLDB1 FOXF2 CACNA1C COL27A1 LRP4 GREB1 PBX3	4.54e-07	187	223	9	c104fbfef2d0bef64077ac721edf2379fd59d547
ToppCell	PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	FREM2 SMPDL3B ALPK3 WWC1 MYOM3 USP43 SHANK2 NKX2-1 SLC16A10	4.96e-07	189	223	9	5d9da836ce4308b8458bb3be3871a0aca734b6cd
ToppCell	RA-14._Fibroblast_III\|RA / Chamber and Cluster_Paper	HIVEP2 GALNT2 TSHZ2 BACH2 BANP ATP13A3 CREM CREB5 EGFR	4.96e-07	189	223	9	46e9a58aacd79db5a02898a8c7244e1884adcfd1
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PHLDB1 CARNS1 COL4A5 CECR2 CREB5 ZFHX4 PLEKHG3 LRP4 GPRC5B	5.42e-07	191	223	9	2110a1dd10730ad7ee7a265fb1716ab3ddafcf4a
ToppCell	10x5'v1-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MAP6 TSHZ2 ARMCX2 PHLDB1 COL15A1 COL27A1 EGFR SETBP1 GREB1	5.42e-07	191	223	9	44b1f62fdee03b157fe545f2ae6ff84f8929a8ac
ToppCell	LA-14._Fibroblast_III\|LA / Chamber and Cluster_Paper	HIVEP2 MAN1A1 GALNT2 TSHZ2 BACH2 BANP CREB5 EGFR ZFHX3	5.91e-07	193	223	9	7426c291bac59e539c427bcaae18abc7d397d44e
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYADM GALNT2 BACH2 MTSS1 AHNAK PWWP2B SETBP1 MED25 CD79A	6.18e-07	194	223	9	d852aebf7a763b9a776c4570711f0c759f591910
ToppCell	LA-14._Fibroblast_III\|World / Chamber and Cluster_Paper	HIVEP2 MAN1A1 GALNT2 TSHZ2 BACH2 BANP CREB5 EGFR ZFHX3	6.18e-07	194	223	9	803fa83ceada17c38ca9f933b888f7e7b0b90761
ToppCell	LA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	TSHZ2 BACH2 PHLDB1 HMCN2 COL15A1 CREB5 EGFR SLC25A13 ZFHX3	6.45e-07	195	223	9	a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCell	distal-Hematologic-EREG+_Dendritic\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LILRB2 NOD2 ATP13A3 CPVL CREM PHC2 SIPA1L1 CSTA SLC16A10	6.73e-07	196	223	9	14c6870d125fc2bdacf4199883399cec0dd3f569
ToppCell	distal-Hematologic-EREG+_Dendritic-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LILRB2 NOD2 ATP13A3 CPVL CREM PHC2 SIPA1L1 CSTA SLC16A10	6.73e-07	196	223	9	c17bb7b3992bfec194bfa310f201a5c64b35868e
ToppCell	Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_monocytic\|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ZBTB16 LILRB2 SULT1A1 AHNAK CPVL FCHO2 CREB5 PHC2 CSTA	6.73e-07	196	223	9	89ff93cbfbe39fbdf2498e8fdc5d61a0ecb26fc9
ToppCell	Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_monocytic-monocyte\|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ZBTB16 LILRB2 SULT1A1 AHNAK CPVL FCHO2 CREB5 PHC2 CSTA	6.73e-07	196	223	9	09574bfeb1d3da53b5471cfb0602946d328b3b5c
ToppCell	Control-Control-Lymphocyte-T/NK-NK_activated\|Control / Disease, condition lineage and cell class	AHNAK NPAS2 SYNE1 OAS3 VWCE NPTXR SETBP1 PABPC1L MDGA1	7.32e-07	198	223	9	76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7
ToppCell	3'_v3-Lung-Myeloid_Monocytic\|Lung / Manually curated celltypes from each tissue	IRF2BP2 LILRB2 MTSS1 ATP13A3 LILRA2 CREB5 PHC2 KLF10 CSTA	7.64e-07	199	223	9	3e14f9a62d6414add8d5f681be184b4625001838
ToppCell	3'_v3-Lung-Myeloid_Monocytic-Classical_monocytes\|Lung / Manually curated celltypes from each tissue	IRF2BP2 LILRB2 SULT1A1 ATP13A3 LILRA2 CREB5 PHC2 KLF10 CSTA	7.64e-07	199	223	9	bfd0d171ea6bb7abd5cdfeac22608cc190aaa2be
ToppCell	severe-Classical_Monocyte\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MYADM LILRB2 SULT1A1 ATP13A3 CPVL LILRA2 CREB5 KLF10 CSTA	7.96e-07	200	223	9	f46689940fdea500ce2457eec412dd2c46705819
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated\|COVID-19_Mild / Disease, condition lineage and cell class	CLSTN3 BTN3A3 AHNAK SYNE1 OAS3 BTN3A2 BTN3A1 PLEKHG3 MYOM2	7.96e-07	200	223	9	2281debd86e5d92e8fe0397aec9ef670800f7471
ToppCell	Adult-Mesenchymal-myofibroblast_cell-D122\|Adult / Lineage, Cell type, age group and donor	ZBTB16 INHA BACH2 PHLDB1 KLHL33 CACNA1C MYOM3 POLQ	1.37e-06	158	223	8	410fa08c9d880d27e80ec939fa5ba5a41dcb31ab
ToppCell	368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	TSHZ2 SLC10A7 HMCN2 SBF1 ARHGAP44 TRAPPC9 E2F2 MYOM2	1.50e-06	160	223	8	19105debef96ea0c267d6a1d332303ec668ae47e
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	HDAC9 MYADM GALNT2 MTSS1 AHNAK SIPA1L1 SETBP1 CD79A	1.73e-06	163	223	8	6bed27d2f67a430a847da5eb47878d14b4949c45
ToppCell	tumor_Lymph_Node_/_Brain-T/NK_cells-CD8_low_T\|T/NK_cells / Location, Cell class and cell subclass	TRERF1 GATA2 SMPDL3B AHNAK BTN3A1 CCK SEC24C SETBP1	1.81e-06	164	223	8	92fb94492fc2b683e9d50a9db6f01d23c194b0e4
ToppCell	3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TCERG1 TIGD3 COL4A5 PCLO ZFHX4 EGFR LRP4 GPRC5B	1.98e-06	166	223	8	9fd9de82f98b9acdaa59ac98fb9664161514aec0
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HDAC9 NOD2 ARHGAP22 KIFC1 POC1A E2F2 CD79A POLQ	2.26e-06	169	223	8	54b13ab02b4c187f4754045ecfcf409749e7ccc0
ToppCell	Monocytes-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	HDAC9 LILRB2 MTSS1 AHNAK TIGD3 CPVL LILRA2 CREB5	2.36e-06	170	223	8	4e93b66b3033e6e4d5f6d2f41974623a53108f5e
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal-Interneuron\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	TRERF1 SLC10A7 ARNT2 CARNS1 CACNA1C CSTA FUT1	3.43e-06	126	223	7	ec445ec097c9c45cd47b8cfa8c140df5b298695e
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRERF1 TSHZ2 DAB1 DCC IRAG1 COL27A1 LRP4 GASK1A	4.08e-06	183	223	8	7eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCell	PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IRF2BP2 LILRB2 SULT1A1 ATP13A3 CPVL LILRA2 KLF10 CSTA	4.08e-06	183	223	8	4763df29c888d47c22076803b054f06b4cc29368
ToppCell	PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IRF2BP2 LILRB2 SULT1A1 ATP13A3 CPVL LILRA2 KLF10 CSTA	4.08e-06	183	223	8	fcb0f755382d88fb207fc2322cd224c09c6e2ea6
ToppCell	Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PHLDB1 CARNS1 COL4A5 CECR2 CREB5 PLEKHG3 LRP4 GPRC5B	4.25e-06	184	223	8	a2191dd5546efd357b23e625beb3c5820476f243
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DAB1 COL27A1 CTXN3 ACVR1C EGFR SIPA1L1 TMEM108 MYOM2	4.25e-06	184	223	8	96926efa220f03d0787322c9519bb9e8f64f74d0
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	LILRB2 MTSS1 SULT1A1 CPVL FCHO2 PABPC1 PHC2 CSTA	4.25e-06	184	223	8	bc0dfe29337f02594e7e0092c9e47dda94b45ad5
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DAB1 COL27A1 CTXN3 ACVR1C EGFR SIPA1L1 TMEM108 MYOM2	4.25e-06	184	223	8	30fddbc9696476d4d7f08e53f84ea994a4ed873a
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TSHZ2 DAB1 DCC IRAG1 EFHC1 ZFHX4 LRP4 AHNAK2	4.42e-06	185	223	8	6712512100ccef456d2e2bd201d0987986c92ac9
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FAM120B CIART BACH2 GATA2 SULT1A1 KMT2A SLC17A5 NUP155	4.60e-06	186	223	8	02418c50fdcca549bf73dedf6199ab4a27862a9b
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FAM120B CIART BACH2 GATA2 SULT1A1 KMT2A SLC17A5 NUP155	4.60e-06	186	223	8	39e475a3c167b33daa63b0c1bfa32451c5f46635
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	IRF2BP2 MEF2D AHNAK PCLO MUC16 CREB5 KLF10 ZFHX3	4.60e-06	186	223	8	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	COVID-19-kidney-Fibroblast-1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TRERF1 TSHZ2 NPAS2 CACNA1C COL15A1 COL27A1 ZFHX4 SETBP1	4.79e-06	187	223	8	76bfe8c42430a230a8bdf299575c444fb7780f24
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ2 ITGA2B AHNAK CPVL WWC1 SYNE1 ZFHX4 EGFR	4.79e-06	187	223	8	9225caf66e06ebe57e90d677122acb6498607f36
ToppCell	Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LILRB2 MTSS1 ATP13A3 CPVL ITSN1 CREM SIPA1L1 SLC16A10	4.98e-06	188	223	8	3be2d50148daa4eddddc2c7f269f45c97f7e4931
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PHLDB1 CARNS1 COL4A5 CECR2 CREB5 PLEKHG3 LRP4 GPRC5B	4.98e-06	188	223	8	60242c29c7f16c94a84685d3bc4ed93a66e70152
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PHLDB1 CARNS1 COL4A5 CECR2 CREB5 ZFHX4 LRP4 GPRC5B	5.18e-06	189	223	8	784ace2be87f2ecb19490f4974f63a559516e0eb
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	TSHZ2 DCC CACNA1C CREB5 SETBP1 ZFHX3 TMEM108 PBX3	5.38e-06	190	223	8	7986586b7c82e91c71102cc8c4d7a689ae63ab4d
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PHLDB1 CARNS1 COL4A5 CECR2 CREB5 ZFHX4 LRP4 GPRC5B	5.38e-06	190	223	8	07f21386ea6eb23416a537d2250e3042efe93fb0
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PHLDB1 CARNS1 COL4A5 CECR2 CREB5 ZFHX4 LRP4 GPRC5B	5.38e-06	190	223	8	ae97df1b06bcd46c05759b53c35dc8fea97f4ac1
ToppCell	Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	HDAC9 MYADM MAN1A1 MTSS1 ITSN1 CREB5 SIPA1L1 SLC16A10	5.38e-06	190	223	8	2d54fca50593fbd11fe13fc2bfaf937a05db776d
ToppCell	LV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	ZBTB16 TSHZ2 PHLDB1 PTBP3 COL15A1 EGFR SLC25A13 ZFHX3	5.38e-06	190	223	8	12992ec80a7b4f4f17de693f0719ee061a9918fd
ToppCell	Primary_Motor_Cortex_(M1)-Non-neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PHLDB1 CARNS1 COL4A5 CECR2 CREB5 ZFHX4 LRP4 GPRC5B	5.59e-06	191	223	8	2b056cbe2e82e056e1f798974999378460eb1d16
ToppCell	LV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	PDXDC1 ZBTB16 TSHZ2 PHLDB1 COL15A1 EGFR SLC25A13 ZFHX3	5.59e-06	191	223	8	d36565257ccba8c1bbed2c1c01be66a9cbb5f834
ToppCell	ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	MAN1A1 TSHZ2 ITGA2B USP31 EFHC1 PCLO ZFHX4 PLEKHG3	5.81e-06	192	223	8	d43caf42ec744e895137f31ef65a990e250669d2
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TRERF1 TSHZ2 IRAG1 FOXF2 CACNA1C LRP4 GREB1 PBX3	5.81e-06	192	223	8	72881b280a415e65f87a80ca1369cbb0b722a0c4
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	ALPK3 ATP13A3 CPVL NPAS2 CACNA1C MYOM3 MYOM2 ALPK2	6.04e-06	193	223	8	dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell	Control-Myeloid-cMonocyte\|World / Disease state, Lineage and Cell class	LILRB2 MTSS1 SULT1A1 ATP13A3 LILRA2 FNDC3A SIPA1L1 CSTA	6.27e-06	194	223	8	f852f5258617a66a4fbd56d64c7b47272e7b8b60
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-Myeloid-Macrophages\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LILRB2 MTSS1 ALPK3 CPVL ITSN1 FCHO2 PHC2 CSTA	6.27e-06	194	223	8	7c7091de47359760003e910cfbe63db5c99410d6
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	LILRB2 SULT1A1 AHNAK CPVL FCHO2 PABPC1 PHC2 CSTA	6.27e-06	194	223	8	a94f9f7179a5733e3c378ff8b337e288785433a1
ToppCell	HSPCs-Mk_prog.\|World / Lineage and Cell class	CLSTN3 MDM1 GATA2 ITGA2B IRAG1 MPL SCARF1 PWWP2B	6.27e-06	194	223	8	5049f4f102844d766eca577e809cf21f7908a9d2
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYADM MTSS1 AHNAK PWWP2B SIPA1L1 SETBP1 MED25 CD79A	6.51e-06	195	223	8	481989d2e5bd2582da3d86b0155c4d6615317067
ToppCell	RV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	ZBTB16 MAN1A1 TSHZ2 PHLDB1 PTBP3 COL15A1 EGFR ZFHX3	6.51e-06	195	223	8	ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCell	RA-02._Fibroblast_II\|RA / Chamber and Cluster_Paper	PDXDC1 ZBTB16 TSHZ2 BACH2 PHLDB1 COL15A1 SETBP1 ZFHX3	6.51e-06	195	223	8	6a02ebbeb3199447ddce64d92d8809436e040eba
ToppCell	COVID-19-kidney-Fibroblast-2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TRERF1 TSHZ2 NPAS2 CACNA1C COL15A1 COL27A1 ZFHX4 SETBP1	6.51e-06	195	223	8	3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2
ToppCell	COVID-19_Severe-Lymphoid_T/NK-gd_T\|COVID-19_Severe / Disease group, lineage and cell class	GFY BTN3A3 AHNAK SYNE1 BTN3A2 BTN3A1 PLEKHG3 MYOM2	6.51e-06	195	223	8	9990440bda7fac5d00ef80444fab07459be625e1
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYADM MTSS1 AHNAK PWWP2B SIPA1L1 SETBP1 MED25 CD79A	6.51e-06	195	223	8	6108a27523d1b93a7fbe35cb95704a5ad9071e3c
ToppCell	severe-Classical_Monocyte\|World / disease stage, cell group and cell class	IRF2BP2 LILRB2 CPVL LILRA2 CREB5 PHC2 KLF10 CSTA	6.51e-06	195	223	8	cf638aac4d57ae0774008920a1a5e9dfd8c73885
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	GFY BTN3A3 AHNAK SYNE1 BTN3A2 BTN3A1 PLEKHG3 MYOM2	6.76e-06	196	223	8	418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c
ToppCell	Adult-Immune-monocyte-D122\|Adult / Lineage, Cell type, age group and donor	HDAC9 LILRB2 MTSS1 UMODL1 CPVL CREB5 PHC2 SIPA1L1	6.76e-06	196	223	8	16b0acb6157534938ca83d4e909471e33a7d3c52
ToppCell	COVID-19-Myeloid-Transitioning_MDM\|COVID-19 / group, cell type (main and fine annotations)	LILRB2 RREB1 ATP13A3 CPVL FNDC3A FCHO2 SIPA1L1 SLC16A10	6.76e-06	196	223	8	4929cfed1f150c1fde4d79cb49895c2ea467a18f
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GFY BTN3A3 AHNAK SYNE1 BTN3A2 BTN3A1 PLEKHG3 MYOM2	6.76e-06	196	223	8	581fc8c8d42005aacd7b401a2c9d1fc331fb4af7
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYADM ZBTB16 MAP4 PVR PTBP3 SF3B1 EGFR AFF4	6.76e-06	196	223	8	151f1a29a91f8b234e9b6ed062666357a2f69128
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	GFY BTN3A3 AHNAK SYNE1 BTN3A2 BTN3A1 PLEKHG3 MYOM2	6.76e-06	196	223	8	6beaf0c2799424c59819b286fbb5c1a83d85e4d1
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GFY BTN3A3 AHNAK SYNE1 BTN3A2 BTN3A1 PLEKHG3 MYOM2	6.76e-06	196	223	8	c35f2349dfe35baa845f790b9f31673dceac54c0
ToppCell	(000)_CD14+_Monocyte\|World / immune cells in Peripheral Blood (logTPM normalization)	MYADM LILRB2 SULT1A1 CPVL LILRA2 CREB5 KLF10 CSTA	7.01e-06	197	223	8	cff498bc7b153f28dd013eaeb73ead4fb62fb44c
ToppCell	Transverse-Dendritic_cell-Lymphoid_DC\|Transverse / Region, Cell class and subclass	ARHGAP22 CLCN5 BANP ITSN1 ACVR1C PLEKHG3 ALPK2 INPP5J	7.01e-06	197	223	8	a58af0ea82f76f2a7abac1f62629ff20d552fc63
ToppCell	Transverse-(5)_Dendritic_cell-(53)_Lymphoid_DC\|Transverse / shred on region, Cell_type, and subtype	ARHGAP22 CLCN5 BANP ITSN1 ACVR1C PLEKHG3 ALPK2 INPP5J	7.01e-06	197	223	8	15b87fd3906d7388c271d30d0c64b1bcc490801c
ToppCell	(0)_Myeloid\|World / immune cells in Peripheral Blood (logTPM normalization)	MYADM LILRB2 SULT1A1 CPVL LILRA2 CREB5 KLF10 CSTA	7.28e-06	198	223	8	aca971ee9d6801bea52288d86b44defa9e306969
ToppCell	(00)_Monocyte\|World / immune cells in Peripheral Blood (logTPM normalization)	MYADM LILRB2 SULT1A1 CPVL LILRA2 CREB5 KLF10 CSTA	7.28e-06	198	223	8	2252e756a8a25d32c16a723e833c1390a772c2a4
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HIVEP2 SNAP91 ARHGAP44 CACNA1C SYNE1 PCLO SHANK2 SETBP1	7.28e-06	198	223	8	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	PBMC-Severe-Myeloid\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYADM LILRB2 SULT1A1 CPVL LILRA2 CREB5 KLF10 CSTA	7.28e-06	198	223	8	a8338da2477ccf8e3d924de8dbe1056b98111532
ToppCell	PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MYADM LILRB2 SULT1A1 CPVL LILRA2 CREB5 KLF10 CSTA	7.28e-06	198	223	8	70e62d815b2a0aa5327ff94d6f4d503176e007b9
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	HDAC9 IRAG1 STARD9 ALPK3 COL4A5 CACNA1C SYNE1 MYOM2	7.28e-06	198	223	8	c12e7511628db819a52959bb68580e27c00c2e41
ToppCell	PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYADM LILRB2 SULT1A1 CPVL LILRA2 CREB5 KLF10 CSTA	7.28e-06	198	223	8	51c220507bb05aa6338fec494b8ecf4902437708
ToppCell	COVID-19_Severe-Classical_Monocyte\|COVID-19_Severe / disease group, cell group and cell class	MYADM LILRB2 SULT1A1 CPVL LILRA2 CREB5 KLF10 CSTA	7.28e-06	198	223	8	b88c4c0ed1abf0a28dbe05b04b9bee1073855ba8
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	HDAC9 IRAG1 STARD9 ALPK3 COL4A5 CACNA1C SYNE1 MYOM2	7.28e-06	198	223	8	22e766df1276c5b14aa0d83f434f47140ebb98ea
ToppCell	PBMC-Severe-Myeloid\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	MYADM LILRB2 SULT1A1 CPVL LILRA2 CREB5 KLF10 CSTA	7.28e-06	198	223	8	603846129560d5d6e6df27d6168f67f592e5e6e2
ToppCell	mild-HLA-DR-_S100A+_Monocyte\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	LILRB2 ATP13A3 CPVL LILRA2 CREB5 KLF10 EGR2 CSTA	7.55e-06	199	223	8	d0d286eafe935f9b3aaba5b783e8911251121b4a
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FREM2 ARHGAP44 WWC1 CECR2 FCHO2 SHANK2 EGFR NKX2-1	7.55e-06	199	223	8	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	COVID-19_Severe-Myeloid\|COVID-19_Severe / Disease group, lineage and cell class	MYADM LILRB2 SULT1A1 CPVL LILRA2 CREB5 KLF10 CSTA	7.55e-06	199	223	8	babbf3220cc811a1794032e06c6cec4dfc7bff2f
ToppCell	COVID_vent-Lymphocytic-ILC-NK_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	CLSTN3 ZBTB16 MTSS1 SYNE1 BTN3A2 BTN3A1 PLEKHG3 MYOM2	7.55e-06	199	223	8	5f914962e2572b0c6372465b81b7496fa663d93c
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	IRF2BP2 BACH2 MAML1 KMT2A ATP13A3 COL4A5 CREB5 ZFHX4	7.55e-06	199	223	8	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	COVID_vent-Lymphocytic-ILC\|COVID_vent / Disease condition, Lineage, Cell class and subclass	CLSTN3 ZBTB16 MTSS1 SYNE1 BTN3A2 BTN3A1 PLEKHG3 MYOM2	7.55e-06	199	223	8	e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a
Drug	Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A	GBF1 KMT2B MAP4 RAD54L2 SBF1 DOCK6 FNDC3A AHCYL2 CREM DALRD3 FUT1 QTRT1	5.15e-07	196	221	12	7226_DN
Drug	5255229; Down 200; 13uM; MCF7; HT_HG-U133A_EA	CEP68 SMPDL3B ARHGAP44 PVR NFYA FH TRMO SLC17A5 CCNT2 NPTXR CSTA FUT1	5.74e-07	198	221	12	833_DN
Drug	Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; PC3; HT_HG-U133A	EPPK1 HIVEP2 KMT2B SMPDL3B CLCN5 TRAPPC9 BTN3A2 DALRD3 SLC17A5 ZNF335 MED25 FUT1	5.74e-07	198	221	12	2069_DN
Drug	Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; PC3; HT_HG-U133A	KMT2B MAML1 MEF2D ARHGAP22 PHLDB1 FBXO22 DOCK6 NPAS2 MED25 INPP5J HR	3.11e-06	193	221	11	4322_UP
Drug	Idoxuridine [54-42-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A	RAD54L2 PHLDB1 SMPDL3B PVR DOCK6 ITSN1 OAS3 FNDC3A AHCYL2 PLEKHG3 INPP5J	3.27e-06	194	221	11	1480_DN
Drug	Diflunisal [22494-42-4]; Down 200; 16uM; MCF7; HT_HG-U133A	MAP4 PHLDB1 NFYA ATP13A3 PRR36 FNDC3A CREM DALRD3 CCNT2 PLEKHG3 QTRT1	4.38e-06	200	221	11	1490_DN
Drug	Calycanthine [595-05-1]; Up 200; 11.6uM; MCF7; HT_HG-U133A	RAD54L2 SBF1 PVR NPAS2 SYNE1 DALRD3 PLEKHG3 SETBP1 MYOM2 AHNAK2	2.01e-05	193	221	10	2764_UP
Drug	Piroxicam [36322-90-4]; Down 200; 12uM; HL60; HG-U133A	SBF1 NFYA ATP13A3 FH PTBP3 LILRA2 TRMO AHCYL2 SEC24C PBX3	2.11e-05	194	221	10	1405_DN
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	KMT2B MAP4 PVR TRAPPC9 WWC1 PTBP3 TRMO AHCYL2 CREM SLC17A5	2.30e-05	196	221	10	987_DN
Drug	Betonicine [515-25-3]; Up 200; 25.2uM; PC3; HT_HG-U133A	MAP4 CDHR2 MEF2D AHNAK PVR HSF1 DPYSL4 FNDC3A BTN3A2 SHANK2	2.30e-05	196	221	10	3745_UP
Drug	5255229; Up 200; 13uM; MCF7; HT_HG-U133A_EA	MAN1A1 CEP68 PHLDB1 CLCN5 ITSN1 OAS3 FNDC3A AHCYL2 CREM HR	2.30e-05	196	221	10	833_UP
Drug	Pempidine tartrate [546-48-5]; Up 200; 13uM; PC3; HT_HG-U133A	KMT2B VPS16 ARHGEF17 AGFG2 KMT2A HSF1 SHANK2 SETBP1 MED25 HR	2.30e-05	196	221	10	4307_UP
Drug	Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; PC3; HT_HG-U133A	MAN1A1 DOCK6 CPVL PTBP3 FNDC3A CREB1 SF3B1 EGFR MED25 AFF4	2.40e-05	197	221	10	2128_DN
Drug	Neostigmine bromide [114-80-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A	GALNT2 MAP4 CLCN5 PVR NFYA PTBP3 ITSN1 OAS3 CREM GPRC5B	2.40e-05	197	221	10	5335_UP
Drug	Piromidic acid [19562-30-2]; Down 200; 13.8uM; MCF7; HT_HG-U133A	MAN1A1 MAP4 GATA2 MAML1 ARMCX2 PRR36 OAS3 AHCYL2 CREM SHANK2	2.40e-05	197	221	10	3335_DN
Drug	Minoxidil [38304-91-5]; Down 200; 19.2uM; PC3; HT_HG-U133A	MAN1A1 KMT2B MDM1 CLCN5 PVR WWC1 PTBP3 TRMO CREB1 BTN3A1	2.40e-05	197	221	10	4216_DN
Drug	Eserine sulfate, physostigmine sulfate [64-47-1]; Down 200; 6.2uM; MCF7; HT_HG-U133A	EPPK1 GATA2 RAD54L2 CEP68 CLCN5 NFYA PTBP3 COL4A5 TRMO QTRT1	2.40e-05	197	221	10	6226_DN
Drug	Benoxinate hydrochloride [5987-82-6]; Down 200; 11.6uM; PC3; HT_HG-U133A	BACH2 GATA2 RAD54L2 BTN3A3 CLCN5 PCLO BTN3A1 SLC17A5 SHANK2 NPTXR	2.40e-05	197	221	10	3996_DN
Drug	Atropine-N-oxide hydrochloride [4574-60-1]; Down 200; 11.8uM; PC3; HT_HG-U133A	CEP68 CLCN5 SBF1 UNKL PCLO TRMO OAS3 DALRD3 MED25 QTRT1	2.51e-05	198	221	10	2054_DN
Drug	Homatropine hydrobromide (R,S) [51-56-9]; Up 200; 11.2uM; PC3; HT_HG-U133A	KMT2B MEF2D ATP13A3 FH NPAS2 TRMO CREB1 CCNT2 EGFR NPTXR	2.51e-05	198	221	10	1806_UP
Drug	Mafenide hydrochloride [138-37-4]; Up 200; 18uM; PC3; HT_HG-U133A	POU6F2 GBF1 ITGA2B MEF2D UNKL SYNE1 NPTXR CD79A ZFHX3 INPP5J	2.51e-05	198	221	10	2124_UP
Drug	Isocarboxazid [59-63-2]; Down 200; 17.2uM; HL60; HT_HG-U133A	ZNF280A KMT2B MAP4 MAML1 PVR TRAPPC9 CCNT2 PLEKHG3 SIPA1L1 QTRT1	2.62e-05	199	221	10	2562_DN
Drug	Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A	HIVEP2 MAML1 RAD54L2 ARHGEF17 PHLDB1 AGFG2 TRAPPC9 AHCYL2 CSTA ZFHX3	2.62e-05	199	221	10	1502_DN
Drug	Thyroxine (L) [51-48-9]; Down 200; 5.2uM; MCF7; HT_HG-U133A	GBF1 GPAA1 SBF1 ARHGAP44 AGFG2 DOCK6 DPYSL4 SLC17A5 IPO9 CSTA	2.62e-05	199	221	10	3249_DN
Drug	Bumetanide [28395-03-1]; Down 200; 11uM; MCF7; HT_HG-U133A	EPPK1 HIVEP2 KMT2B SBF1 PVR NFYA PTBP3 CREM CCNT2 ZNF335	2.62e-05	199	221	10	5542_DN
Drug	AC1L577W	SULT1A2 SULT1A1 CD79A	3.07e-05	7	221	3	CID000171279
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA	NCOA6 RREB1 TCERG1 BANP TRMO DIDO1 RIF1 ZFHX3 GREB1	5.56e-05	175	221	9	1058_DN
Drug	ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A	CEP68 CLCN5 PVR NFYA FH CCNT2 KLF10 GREB1 SLC16A10	6.91e-05	180	221	9	5202_DN
Drug	Fenoterol hydrobromide [1944-12-3]; Up 200; 10.4uM; PC3; HT_HG-U133A	MAN1A1 GATA2 MEF2D PHLDB1 PVR ARNT2 NPAS2 CREM AFF4	7.53e-05	182	221	9	6331_UP
Drug	0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A	HIVEP2 CEP68 BANP ARNT2 CREB1 CREM RFWD3 TDRD7 SHANK2	8.53e-05	185	221	9	4755_DN
Drug	5-hydroxymethylfurfural	SULT1A2 SULT1A1	9.38e-05	2	221	2	ctd:C008046
Drug	ipronidazole	NCOA6 MST1R	9.38e-05	2	221	2	CID000026951
Drug	semduramicin	NCOA6 SHANK2	9.38e-05	2	221	2	CID000071327
Drug	2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A_EA	MTSS1 ARMCX2 CLCN5 AGFG2 PRR36 DPYSL4 EGFR GPRC5B AHNAK2	1.00e-04	189	221	9	989_UP
Drug	5707885; Down 200; 50uM; PC3; HT_HG-U133A	MTSS1 RAD54L2 MEF2D CEP68 PVR PRR36 BTN3A2 PLEKHG3 MED25	1.09e-04	191	221	9	6390_DN
Drug	Nifuroxazide [965-52-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A	MAP4 ARHGEF17 AGFG2 WWC1 DPYSL4 FNDC3A CCNT2 INPP5J GPRC5B	1.09e-04	191	221	9	2850_DN
Drug	Calciferol [50-14-6]; Down 200; 10uM; PC3; HT_HG-U133A	SMPDL3B CLCN5 PVR AGFG2 HSF1 PTBP3 SYNE1 AHCYL2 CCNT2	1.09e-04	191	221	9	6746_DN
Drug	Estriol [50-27-1]; Down 200; 13.8uM; MCF7; HT_HG-U133A	MAP4 GATA2 SBF1 PVR PTBP3 COL4A5 DPYSL4 ZNF335 ZFHX3	1.09e-04	191	221	9	7220_DN
Drug	Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; PC3; HT_HG-U133A	CEP68 SBF1 PVR KMT2A NPAS2 PCLO SF3B1 EGFR PLEKHG3	1.13e-04	192	221	9	5058_DN
Drug	Acetohexamide [968-81-0]; Up 200; 12.4uM; PC3; HT_HG-U133A	KMT2B ITGA2B ARHGAP44 AGFG2 KMT2A ATP13A3 TRMO OAS3 TDRD7	1.13e-04	192	221	9	1829_UP
Drug	Cetirizine dihydrochloride [83881-52-1]; Up 200; 8.6uM; MCF7; HT_HG-U133A	CLSTN3 HIVEP2 MAML1 RAD54L2 ARMCX2 PVR BTN3A1 GREB1 SLC16A10	1.18e-04	193	221	9	2829_UP
Drug	17-AAG; Down 200; 1uM; PC3; HT_HG-U133A	MAN1A1 CEP68 PHLDB1 SMPDL3B PVR AGFG2 OAS3 PLEKHG3 MED25	1.18e-04	193	221	9	5919_DN
Drug	Azacytidine-5 [320-67-2]; Up 200; 16.4uM; MCF7; HT_HG-U133A	KMT2B MAP4 CDHR2 ITGA2B AHNAK CREB5 KLF10 MED25 QTRT1	1.18e-04	193	221	9	3348_UP
Drug	Indomethacin [53-86-1]; Down 200; 11.2uM; MCF7; HT_HG-U133A	MAN1A1 MAP4 NACA CEP68 CPSF4 TRAPPC9 ITSN1 NPTXR GREB1	1.18e-04	193	221	9	7409_DN
Drug	Chloroprene	HDAC9 ZBTB16 GBF1 MDM1 MTSS1 GATA2 ARMCX2 EFHC1 SULT1A1 DDHD2 FOXF2 NPAS2 CACNA1C POC1A USP43 TMEM119 PABPC1 RIF1 SF3B1 FAM193A KLF10 ZFHX4 EGFR EGR2 ARID2 CD79A SDCBP2 AFF4	1.21e-04	1348	221	28	ctd:D002737
Drug	Glycocholic acid [475-31-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A	EPPK1 GALNT2 MAP4 NACA MTSS1 GATA2 AGFG2 CREB1 SIPA1L1	1.23e-04	194	221	9	5316_DN
Drug	Diphenidol hydrochloride [3254-89-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A	MAP4 ARHGAP44 NFYA DOCK6 PTBP3 RALGAPB TRMO AHCYL2 QTRT1	1.23e-04	194	221	9	7406_DN
Drug	Cholecalciferol [67-97-0]; Down 200; 10.4uM; PC3; HT_HG-U133A	GATA2 RAD54L2 MEF2D PTBP3 SYNE1 BTN3A2 SETBP1 ZFHX3 HR	1.23e-04	194	221	9	6656_DN
Drug	2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A_EA	MTSS1 ARMCX2 CLCN5 PTBP3 DPYSL4 SLC17A5 EGFR GPRC5B HR	1.23e-04	194	221	9	1020_UP
Drug	Indapamide [26807-65-8]; Down 200; 10.6uM; PC3; HT_HG-U133A	BACH2 CLCN5 PTBP3 SYNE1 TRMO CREM BTN3A1 DALRD3 MED25	1.27e-04	195	221	9	3778_DN
Drug	Acacetin [480-44-4]; Up 200; 14uM; PC3; HT_HG-U133A	KMT2B ARHGEF17 MEF2D CEP68 KMT2A FOXF2 CREM PLEKHG3 MED25	1.32e-04	196	221	9	4324_UP
Drug	fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A	MAP4 MDM1 GATA2 BBS1 FH WWC1 PTBP3 NSD1 GPRC5B	1.32e-04	196	221	9	6954_DN
Drug	Trapidil [15421-84-8]; Down 200; 19.4uM; HL60; HT_HG-U133A	MAP4 LILRB2 SBF1 PVR DOCK6 TRAPPC9 PTBP3 BTN3A1 ZFHX3	1.32e-04	196	221	9	3136_DN
Drug	Phenelzine sulfate [156-51-4]; Down 200; 17uM; PC3; HT_HG-U133A	HDAC9 GATA2 ARMCX2 CEP68 TRMO CREM NPTXR MED25 FUT1	1.32e-04	196	221	9	4538_DN
Drug	Tranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; PC3; HT_HG-U133A	ARHGEF17 ARHGAP22 PHLDB1 NFYA ALPK3 PRR36 PCLO ITSN1 SCARF1	1.32e-04	196	221	9	2101_UP
Drug	Glycocholic acid [475-31-0]; Up 200; 8.6uM; MCF7; HT_HG-U133A	ZNF280A MAP4 RAD54L2 PHLDB1 KMT2A PRR36 ITSN1 CCNT2 GREB1	1.32e-04	196	221	9	3315_UP
Drug	Nocodazole [31430-18-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A	GATA2 ARMCX2 CEP68 SBF1 NFYA CCNT2 NPTXR PLEKHG3 HR	1.32e-04	196	221	9	2239_DN
Drug	Acetopromazine maleate salt [3598-37-6]; Up 200; 9uM; MCF7; HT_HG-U133A	HDAC9 MEF2D NOD2 SHANK2 NKX2-1 GREB1 INPP5J AFF4 AHNAK2	1.32e-04	196	221	9	6832_UP
Drug	2-Chloropyrazine [14508-49-7]; Down 200; 35uM; MCF7; HT_HG-U133A	GALNT2 MAP4 RAD54L2 FBXO22 PVR NFYA ITSN1 PLEKHG3 FUT1	1.32e-04	196	221	9	6227_DN
Drug	Cytisine (-) [485-35-8]; Down 200; 21uM; MCF7; HT_HG-U133A	MAP4 MDM1 RAD54L2 CLCN5 PTBP3 AHCYL2 PLEKHG3 GREB1 QTRT1	1.38e-04	197	221	9	6217_DN
Drug	Cytisine (-) [485-35-8]; Up 200; 21uM; MCF7; HT_HG-U133A	ACADS RAD54L2 ARHGEF17 PVR DOCK6 LILRA2 PRR36 ZFHX4 PLEKHG3	1.38e-04	197	221	9	2759_UP
Drug	Arecoline hydrobromide [300-08-3]; Up 200; 17uM; PC3; HT_HG-U133A	HDAC9 GATA2 RAD54L2 DPYSL4 TRMO BTN3A2 CSTA CD79A INPP5J	1.38e-04	197	221	9	6322_UP
Drug	Tinidazole [19387-91-8]; Up 200; 16.2uM; HL60; HT_HG-U133A	POU6F2 ACADS MAP4 CLCN5 AHCYL2 NCAN MED25 FUT5 HR	1.38e-04	197	221	9	2568_UP
Drug	Vitamin K2 [11032-49-8]; Down 200; 9uM; PC3; HT_HG-U133A	HIVEP2 MEF2D AHNAK ALPK3 AGFG2 KMT2A NPAS2 PTBP3 BTN3A2	1.38e-04	197	221	9	3798_DN
Drug	estradiol, USP; Up 200; 0.01uM; MCF7; HG-U133A	ACADS MAP4 CEP68 ARNT2 NFYA TRMO CREB1 ZFHX3 QTRT1	1.38e-04	197	221	9	121_UP
Drug	Bromocryptine mesylate [22260-51-1]; Down 200; 5.4uM; MCF7; HT_HG-U133A	MAN1A1 MAP4 GATA2 PTBP3 PRR36 DIDO1 SLC17A5 EGFR GPRC5B	1.38e-04	197	221	9	1507_DN
Drug	Conessine [546-06-5]; Up 200; 11.2uM; HL60; HT_HG-U133A	ITGA2B CEP68 SBF1 DOCK6 LILRA2 CREM RIF1 MED25 GPRC5B	1.38e-04	197	221	9	2135_UP
Drug	Sulfamerazine [127-79-7]; Up 200; 15.2uM; MCF7; HT_HG-U133A	HDAC9 MTSS1 TRAPPC9 MPL CACNA1C LILRA2 E2F2 GREB1 FUT5	1.38e-04	197	221	9	3616_UP
Drug	Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A	ACADS MAML1 RAD54L2 SMPDL3B SBF1 WWC1 PRR36 CSTA GPRC5B	1.38e-04	197	221	9	3829_DN
Drug	Ganciclovir [82410-32-0]; Down 200; 15.6uM; PC3; HT_HG-U133A	EPPK1 HIVEP2 MAP4 BTN3A3 DIDO1 BTN3A1 SHANK2 SETBP1 MED25	1.38e-04	197	221	9	6289_DN
Drug	Pivampicillin [33817-20-8]; Up 200; 8.6uM; HL60; HT_HG-U133A	GBF1 ACADS PVR DOCK6 OAS3 BTN3A1 SHANK2 ZFHX4 INPP5J	1.38e-04	197	221	9	2945_UP
Drug	Meropenem [96036-03-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A	MAN1A1 KMT2B PHLDB1 FBXO22 SMPDL3B PTBP3 DPYSL4 EGFR QTRT1	1.38e-04	197	221	9	7180_UP
Drug	Retinoic acid [302-79-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A	NFYA COL4A5 PRR36 AHCYL2 NPTXR ZFHX3 GREB1 AFF4 HR	1.38e-04	197	221	9	3165_DN
Drug	Florfenicol [73231-34-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A	HIVEP2 NACA PVR AGFG2 ITSN1 CREB1 ZNF335 ZFHX3 QTRT1	1.38e-04	197	221	9	5300_DN
Drug	Orlistat; Down 200; 10uM; PC3; HT_HG-U133A	CLSTN3 BACH2 PVR ALPK3 HSF1 PRR36 BTN3A2 PLEKHG3 MED25	1.43e-04	198	221	9	6388_DN
Drug	Loxapine succinate [27833-64-3]; Up 200; 9uM; MCF7; HT_HG-U133A	CLSTN3 INHA ITSN1 BTN3A1 SLC17A5 ZFHX4 MED25 LRP4 HR	1.43e-04	198	221	9	1516_UP
Drug	Trichlorfon [52-68-6]; Down 200; 15.6uM; HL60; HT_HG-U133A	MAP4 CEP68 TRMO OAS3 BTN3A1 DALRD3 PHC2 CCNT2 QTRT1	1.43e-04	198	221	9	1839_DN
Drug	Danazol [17230-88-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A	HIVEP2 MAN1A1 CEP68 PVR NFYA DOCK6 CREM EGFR ZFHX3	1.43e-04	198	221	9	1538_DN
Drug	(S)-propranolol hydrochloride [4199-10-4]; Down 200; 13.6uM; PC3; HT_HG-U133A	HDAC9 HIVEP2 MDM1 PVR CREB1 BTN3A1 SLC17A5 CCNT2 MED25	1.43e-04	198	221	9	6343_DN
Drug	wortmannin from Penicillium funiculosum; Up 200; 0.01uM; HL60; HT_HG-U133A	MAN1A1 ACADS CDHR2 MTSS1 NOD2 CACNA1C OAS3 RIF1 MED25	1.43e-04	198	221	9	6202_UP
Drug	Aspartic acid, N-acetyl (R,S) [997-55-7]; Up 200; 22.8uM; PC3; HT_HG-U133A	CLSTN3 ACADS ARHGEF17 PHLDB1 FBXO22 PVR HSF1 PTBP3 BTN3A2	1.43e-04	198	221	9	4007_UP
Drug	Dienestrol [84-17-3]; Down 200; 15uM; MCF7; HT_HG-U133A	HIVEP2 MAP4 GATA2 RAD54L2 NFYA PTBP3 FNDC3A CREM ZFHX3	1.43e-04	198	221	9	6208_DN
Drug	Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; MCF7; HT_HG-U133A	GBF1 MAP4 FBXO22 CLCN5 SBF1 NFYA PRR36 DIDO1 PLEKHG3	1.43e-04	198	221	9	4791_DN
Drug	Metronidazole [443-48-1]; Down 200; 23.4uM; MCF7; HT_HG-U133A	ACADS MAP4 PVR AGFG2 ITSN1 OAS3 FNDC3A DALRD3 INPP5J	1.43e-04	198	221	9	1503_DN
Drug	Graveoline [485-61-0]; Up 200; 14.4uM; MCF7; HT_HG-U133A	GABRR1 ALLC CDHR2 ITGA2B ARHGEF17 PVR CD79A FUT5 HR	1.43e-04	198	221	9	6034_UP
Drug	Dimaprit dihydrochloride [23256-33-9]; Up 200; 17uM; MCF7; HT_HG-U133A	HIVEP2 ARMCX2 PHLDB1 AGFG2 TRAPPC9 MST1R MED25 GREB1 AHNAK2	1.43e-04	198	221	9	6520_UP
Drug	Dioxybenzone [131-53-3]; Down 200; 16.4uM; MCF7; HT_HG-U133A	HIVEP2 KMT2B MAP4 PTBP3 CREM SLC17A5 IPO9 EGFR PLEKHG3	1.43e-04	198	221	9	5699_DN
Drug	Cephalothin sodium salt [58-71-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A	ACADS MEF2D NOD2 KMT2A DOCK6 TRAPPC9 FNDC3A AHCYL2 EGFR	1.43e-04	198	221	9	6819_UP
Drug	Dacarbazine [4342-03-4]; Up 200; 22uM; MCF7; HT_HG-U133A	LILRB2 PVR AGFG2 DOCK6 FNDC3A MST1R MED25 FUT5 INPP5J	1.48e-04	199	221	9	6816_UP
Drug	Ricinine [524-40-3]; Down 200; 24.4uM; PC3; HT_HG-U133A	GATA2 RAD54L2 SBF1 NPAS2 PTBP3 BTN3A1 CREB5 SETBP1 MED25	1.48e-04	199	221	9	5725_DN
Drug	Suxibuzone [27470-51-5]; Up 200; 9.2uM; PC3; HT_HG-U133A	MAN1A1 ITGA2B MEF2D ARNT2 TRMO FNDC3A CCK CCNT2 NPTXR	1.48e-04	199	221	9	5806_UP
Drug	Flurbiprofen [5104-49-4]; Up 200; 16.4uM; HL60; HT_HG-U133A	MAP4 TSHZ2 VPS16 CLCN5 NPAS2 PCLO CREM RIF1 SIPA1L1	1.48e-04	199	221	9	3095_UP
Drug	Trichlorfon [52-68-6]; Up 200; 15.6uM; PC3; HT_HG-U133A	KMT2B RREB1 CEP68 NFYA AGFG2 ATP13A3 TRMO FNDC3A CCNT2	1.48e-04	199	221	9	1797_UP
Drug	Demeclocycline hydrochloride [64-73-3]; Up 200; 8uM; HL60; HT_HG-U133A	MAP4 LILRB2 AHNAK TRAPPC9 CREM PLEKHG3 MED25 AFF4 HR	1.48e-04	199	221	9	2545_UP
Drug	prednisolone; Up 200; 1uM; MCF7; HG-U133A	ARHGAP22 AGFG2 FH LILRA2 ITSN1 FNDC3A PLEKHG3 ZNF335 SETBP1	1.48e-04	199	221	9	265_UP
Drug	Acemetacin [53164-05-9]; Down 200; 9.6uM; PC3; HT_HG-U133A	HDAC9 EPPK1 KMT2B MAP4 SBF1 CCNT2 SHANK2 SETBP1 ZFHX3	1.48e-04	199	221	9	6361_DN
Drug	Sulmazole [73384-60-8]; Up 200; 14uM; HL60; HT_HG-U133A	MAP4 PVR KMT2A DOCK6 SYNE1 BTN3A1 PHC2 MED25 AHNAK2	1.48e-04	199	221	9	2153_UP
Drug	Isoniazid [54-85-3]; Down 200; 29.2uM; PC3; HT_HG-U133A	EPPK1 PVR WWC1 SYNE1 TRMO DIDO1 CREM ZNF335 MED25	1.48e-04	199	221	9	2083_DN
Drug	Epirizole [18694-40-1]; Down 200; 17uM; MCF7; HT_HG-U133A	GPAA1 COL4A5 PRR36 TRMO CREM SLC17A5 RIF1 PLEKHG3 GPRC5B	1.54e-04	200	221	9	1681_DN
Drug	Palmatine chloride [3486-67-7]; Down 200; 10.4uM; PC3; HT_HG-U133A	MAP4 LILRB2 RAD54L2 PVR KMT2A SYNE1 TRMO AHCYL2 QTRT1	1.54e-04	200	221	9	6612_DN
Disease	Bipolar Disorder	GABRR1 ACADS NOD2 STARD9 NPAS2 CACNA1C SYNE1 PCLO CREB1 SHANK2 SEC24C EGR2 NCAN MDGA1	1.73e-05	477	222	14	C0005586
Disease	intellectual disability (implicated_via_orthology)	ZNF280A HIVEP2 ITGA2B MEF2D TRAPPC9 ITSN1	2.21e-05	75	222	6	DOID:1059 (implicated_via_orthology)
Disease	unipolar depression, bipolar disorder	ACADS DCC STARD9 CACNA1C SYNE1 PCLO NCAN SETBP1	2.53e-05	156	222	8	EFO_0003761, MONDO_0004985
Disease	platelet component distribution width	HDAC9 HIVEP2 GALNT2 MTSS1 ITGA2B TLX1 SIRPG CEP68 PVR ATP13A3 NPAS2 CACNA1C SYNE1 TRMO C4orf54 EGFR PLEKHG3	6.41e-05	755	222	17	EFO_0007984
Disease	Chloracne	EPPK1 AHNAK CREM EGFR	1.08e-04	33	222	4	C0263454
Disease	bipolar disorder	HDAC9 HIVEP2 SNAP91 STARD9 CACNA1C SYNE1 PCLO MYOM3 BTN3A2 BTN3A1 SF3B1 SHANK2 NCAN TMEM108	1.33e-04	577	222	14	MONDO_0004985
Disease	metabolite measurement, diet measurement	PDXDC1 AHNAK BTN3A2 MST1R ZNF335	2.00e-04	71	222	5	EFO_0004725, EFO_0008111
Disease	Chromosome Aberrations	SULT1A2 SULT1A1 KMT2A	2.19e-04	16	222	3	C0008625
Disease	Autosome Abnormalities	SULT1A2 SULT1A1 KMT2A	2.19e-04	16	222	3	C0004403
Disease	Manic	STARD9 CACNA1C CCK SHANK2 NCAN	3.11e-04	78	222	5	C0338831
Disease	schizophrenia, intelligence, self reported educational attainment	PDXDC1 MAP4 DCC SNAP91 DENND6B KMT2A CACNA1C CREB1 SF3B1 EGR2	3.15e-04	346	222	10	EFO_0004337, EFO_0004784, MONDO_0005090
Disease	syndrome (implicated_via_orthology)	SLC10A7 NSD1 CNOT1	3.15e-04	18	222	3	DOID:225 (implicated_via_orthology)
Disease	Leukemia, Myelocytic, Acute	BACH2 GATA2 PVR KMT2A NSD1 SF3B1 SETBP1	3.52e-04	173	222	7	C0023467
Disease	alcohol consumption measurement	POU6F2 TSHZ2 BBS1 DCC SULT1A1 SNAP91 SEC23B WWC1 NPAS2 TOM1L2 CACNA1C PCLO PHC2 MST1R IPO9 ARID2 SETBP1 ZFHX3 AFF4 GPRC5B SLC16A10	4.85e-04	1242	222	21	EFO_0007878
Disease	Weaver syndrome	KMT2A NSD1	5.55e-04	5	222	2	C0265210
Disease	Aneuploidy	CKAP5 TLX1	5.55e-04	5	222	2	C0002938
Disease	Myelodysplastic syndrome	GATA2 SF3B1	5.55e-04	5	222	2	cv:C3463824
Disease	MYELODYSPLASTIC SYNDROME	GATA2 SF3B1	5.55e-04	5	222	2	614286
Disease	Nasopharyngeal carcinoma	SYNE1 MST1R CSTA	5.82e-04	22	222	3	C2931822
Disease	Acute Cerebrovascular Accidents	HDAC9 ITGA2B FOXF2 ZFHX3	7.35e-04	54	222	4	C0751956
Disease	cortical thickness	HDAC9 IRF2BP2 ZBTB16 KMT2B MDM1 DAB1 RREB1 IRAG1 PHLDB1 SNAP91 UMODL1 KMT2A CPVL TOM1L2 DPYSL4 SF3B1 EGFR LRP4 TMEM108	8.05e-04	1113	222	19	EFO_0004840
Disease	Benign neoplasm of esophagus	DCC EGFR	8.29e-04	6	222	2	C0153942
Disease	N-acetylalanine measurement	ACY1 POC1A	8.29e-04	6	222	2	EFO_0800118
Disease	Carcinoma in situ of esophagus	DCC EGFR	8.29e-04	6	222	2	C0154059
Disease	bipolar disorder, anorexia nervosa	SLC10A7 CACNA1C	8.29e-04	6	222	2	MONDO_0004985, MONDO_0005351
Disease	level of Phosphatidylcholine (18:1_20:3) in blood serum	PDXDC1 NCAN	8.29e-04	6	222	2	OBA_2045103
Disease	Prostatic Neoplasms	ZBTB16 SULT1A1 PVR KMT2A CHD6 COL15A1 ITSN1 AHCYL2 SF3B1 EGFR ARID2 ZFHX3 GREB1	8.52e-04	616	222	13	C0033578
Disease	Malignant neoplasm of prostate	ZBTB16 SULT1A1 PVR KMT2A CHD6 COL15A1 ITSN1 AHCYL2 SF3B1 EGFR ARID2 ZFHX3 GREB1	8.52e-04	616	222	13	C0376358
Disease	serum metabolite measurement	PDXDC1 POU6F2 GPAA1 GALNT2 ACADS CKAP5 ACY1 SULT1A2 CPSF4 DOCK6 FOXF2 POC1A COL27A1 ZFHX3 MYOM2 MDGA1 SLC16A10	8.61e-04	945	222	17	EFO_0005653
Disease	grapefruit juice consumption measurement	CACNA1C PCLO	1.15e-03	7	222	2	EFO_0010094
Disease	N-formylmethionine measurement	ACY1 POC1A	1.15e-03	7	222	2	EFO_0800128
Disease	Esophageal carcinoma	DCC EGFR	1.15e-03	7	222	2	C0152018
Disease	Cerebrovascular accident	HDAC9 ITGA2B FOXF2 ZFHX3	1.24e-03	62	222	4	C0038454
Disease	central nervous system cancer, glioma	ZBTB16 PHLDB1 EGFR	1.33e-03	29	222	3	EFO_0000326, EFO_0005543
Disease	myelofibrosis (is_implicated_in)	KMT2A MPL	1.53e-03	8	222	2	DOID:4971 (is_implicated_in)
Disease	central nervous system cancer	ZBTB16 PHLDB1 EGFR	1.62e-03	31	222	3	EFO_0000326
Disease	MYELODYSPLASTIC SYNDROME	GATA2 MPL SF3B1 SETBP1	1.65e-03	67	222	4	C3463824
Disease	colorectal adenoma	DAB1 NOD2 FAM193A	1.94e-03	33	222	3	EFO_0005406
Disease	mean platelet volume	HDAC9 ZBTB16 HIVEP2 GALNT2 NACA ITGA2B IRAG1 SIRPG EFHC1 FBXO28 PVR ATP13A3 TRMO FCHO2 SCARF1 GORASP2 SETBP1	1.94e-03	1020	222	17	EFO_0004584
Disease	22q11 partial monosomy syndrome	RREB1 SEC24C	1.96e-03	9	222	2	C3266101
Disease	gamma-glutamylisoleucine measurement	LILRB2 CARNS1	1.96e-03	9	222	2	EFO_0021139
Disease	signal-regulatory protein beta-1 measurement	SIRPG SDCBP2	1.96e-03	9	222	2	EFO_0802069
Disease	Manic Disorder	STARD9 CACNA1C SHANK2 NCAN	2.04e-03	71	222	4	C0024713
Disease	insomnia measurement	PDXDC1 HDAC9 DAB1 DCC RREB1 KMT2A MNT MDGA1 GASK1A GPRC5B	2.05e-03	443	222	10	EFO_0007876
Disease	age at menopause	TNRC18 BANP CHD6 DIDO1 CCNT2 RIF1 GORASP2 ZFHX4	2.15e-03	302	222	8	EFO_0004704
Disease	serum IgG glycosylation measurement	POU6F2 CLSTN3 HIVEP2 BACH2 MTSS1 SBF1 UMODL1 FGF4 EGR2 MDGA1 GPRC5B	2.16e-03	523	222	11	EFO_0005193
Disease	coronary aneurysm	TSHZ2 SETBP1 MDGA1	2.30e-03	35	222	3	EFO_1000881
Disease	wellbeing measurement	RAB19 HIVEP2 GALNT2 DAB1 DCC KMT2A PCLO BTN3A2 EGFR NPTXR RP1L1 LRP4 ZFHX3	2.38e-03	692	222	13	EFO_0007869
Disease	Asymmetric crying face association	RREB1 SEC24C	2.44e-03	10	222	2	C0431406
Disease	22q11 Deletion Syndrome	RREB1 SEC24C	2.44e-03	10	222	2	C2936346
Disease	Acute Myeloid Leukemia, M1	BACH2 GATA2 PVR KMT2A NSD1	2.60e-03	125	222	5	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	BACH2 GATA2 PVR KMT2A NSD1	2.60e-03	125	222	5	C1879321
Disease	red blood cell density measurement	PDXDC1 IRF2BP2 FAM120B ZBTB16 ACADS BACH2 RREB1 SULT1A1 CACNA1C ITSN1 E2F2 FCHO2 PHC2 ARID2 SLC16A10	2.87e-03	880	222	15	EFO_0007978
Disease	hepatocyte growth factor-like protein measurement	RAD54L2 BSN POC1A	2.92e-03	38	222	3	EFO_0008154
Disease	nucleus accumbens volume change measurement	WWC1 MUC16	2.96e-03	11	222	2	EFO_0021493
Disease	Depression, Bipolar	STARD9 CACNA1C SHANK2 NCAN	3.02e-03	79	222	4	C0005587
Disease	neuroimaging measurement	PDXDC1 HDAC9 ZBTB16 KMT2B DAB1 DCC RREB1 IRAG1 ARHGAP22 SNAP91 CPVL WWC1 DPYSL4 CREB1 EGFR PBX3 CRTC2	3.14e-03	1069	222	17	EFO_0004346
Disease	small cell lung carcinoma	BAG6 FCHO2 BTN3A1 PHC1	3.16e-03	80	222	4	EFO_0000702
Disease	eotaxin measurement	ZBTB16 RREB1 MEF2D GASK1A	3.16e-03	80	222	4	EFO_0008122
Disease	multiple system atrophy	RREB1 USP31 ARHGAP44	3.38e-03	40	222	3	EFO_1001050
Disease	autism spectrum disorder, schizophrenia	SNAP91 ALPK3 CACNA1C BTN3A2 BTN3A1 SF3B1 SIPA1L1 CNOT1	3.49e-03	327	222	8	EFO_0003756, MONDO_0005090
Disease	acute myeloid leukemia (implicated_via_orthology)	KMT2A SF3B1	3.54e-03	12	222	2	DOID:9119 (implicated_via_orthology)
Disease	X-12707 measurement	SULT1A2 SULT1A1	3.54e-03	12	222	2	EFO_0800720
Disease	Unipolar Depression	HDAC9 ZBTB16 CACNA1C PCLO CREB1 SEC24C EGFR	3.60e-03	259	222	7	C0041696
Disease	Carcinoma, Transitional Cell	KMT2A CHD6 PABPC1	3.63e-03	41	222	3	C0007138
Disease	response to anticoagulant	TSHZ2 CPVL CACNA1C	3.63e-03	41	222	3	GO_0061476
Disease	Autistic Disorder	POU6F2 DAB1 NPAS2 CACNA1C NSD1 SHANK2 EGR2	3.75e-03	261	222	7	C0004352
Disease	Proteinuria	CLCN5 COL4A5 MUC16	4.15e-03	43	222	3	C0033687
Disease	Charcot-Marie-Tooth disease type 4	SBF1 EGR2	4.16e-03	13	222	2	cv:C4082197
Disease	Bladder Neoplasm	KMT2A CHD6 PABPC1 EGFR NCAN	4.23e-03	140	222	5	C0005695
Disease	bipolar I disorder	STARD9 CACNA1C SYNE1 SHANK2 NCAN	4.36e-03	141	222	5	EFO_0009963
Disease	Malignant neoplasm of urinary bladder	KMT2A CHD6 PABPC1 EGFR NCAN	4.36e-03	141	222	5	C0005684
Disease	mean corpuscular hemoglobin concentration	HDAC9 IRF2BP2 ZBTB16 GPAA1 GALNT2 BACH2 RREB1 ITSN1 E2F2 FCHO2 CREB1 PABPC1 RIF1 EGFR NCAN RP1L1 SLC16A10	4.37e-03	1105	222	17	EFO_0004528
Disease	dystonia (is_implicated_in)	KMT2B VPS16	4.83e-03	14	222	2	DOID:543 (is_implicated_in)
Disease	ascorbic acid 3-sulfate measurement	SULT1A2 SULT1A1	4.83e-03	14	222	2	EFO_0800173
Disease	middle cerebral artery infarction (biomarker_via_orthology)	HDAC9 NOD2 SNAP91 EGR2	5.40e-03	93	222	4	DOID:3525 (biomarker_via_orthology)
Disease	intraocular pressure measurement	ALLC POU6F2 CKAP5 EFHC1 KMT2A NPAS2 PCLO TMEM119 LRP4 ZFHX3	5.45e-03	509	222	10	EFO_0004695
Disease	risk-taking behaviour	FAM120B TSHZ2 BACH2 DAB1 DCC SULT1A2 SULT1A1 CACNA1C PHC2 EGR2 RP1L1 LRP4 ZFHX3	5.46e-03	764	222	13	EFO_0008579
Disease	Opioid use measurement	MYOM2 PBX3	5.55e-03	15	222	2	EFO_0009937
Disease	Autosomal recessive primary microcephaly	PHC1 ZNF335	5.55e-03	15	222	2	cv:C3711387
Disease	age at menarche	FAM120B PSMG3-AS1 SNAP91 BSN FNDC3A ZFHX4 NKX2-1 NPTXR TMEM108 GREB1 GPRC5B	5.61e-03	594	222	11	EFO_0004703
Disease	platelet crit	HDAC9 ZBTB16 GALNT2 BACH2 GATA2 ITGA2B RREB1 MEF2D SIRPG BANP MPL CACNA1C SCARF1 EGFR NCAN	5.88e-03	952	222	15	EFO_0007985
Disease	lung adenocarcinoma (is_implicated_in)	SULT1A1 EGFR ZFHX3	6.00e-03	49	222	3	DOID:3910 (is_implicated_in)
Disease	diet measurement	PDXDC1 HDAC9 RAB19 NCOA6 BTN3A3 CHD6 EGR2 ARID2 SLC25A13 ZFHX3 TMEM108 FUT1 PBX3 MDGA1 CNOT1 CRTC2	6.10e-03	1049	222	16	EFO_0008111
Disease	DiGeorge Syndrome	RREB1 SEC24C	6.31e-03	16	222	2	C0012236
Disease	CONOTRUNCAL ANOMALY FACE SYNDROME	RREB1 SEC24C	6.31e-03	16	222	2	C0795907
Disease	lysosomal storage disease (implicated_via_orthology)	VPS16 SLC17A5	6.31e-03	16	222	2	DOID:3211 (implicated_via_orthology)
Disease	Dermatitis	NOD2 EGFR	6.31e-03	16	222	2	C0011603
Disease	response to acetylsalicylate	MAP4 DAB1	6.31e-03	16	222	2	GO_1903492
Disease	Shprintzen syndrome	RREB1 SEC24C	6.31e-03	16	222	2	C0220704
Disease	polyunsaturated fatty acids to total fatty acids percentage	PDXDC1 GALNT2 ZNF335	6.35e-03	50	222	3	EFO_0022303
Disease	sleep duration	HDAC9 GBF1 DAB1 KMT2A EGR2 PABPC1L PBX3 GPRC5B	6.36e-03	362	222	8	EFO_0005271
Disease	major depressive disorder	HIVEP2 DCC BSN PCLO BTN3A2	6.47e-03	155	222	5	MONDO_0002009
Disease	Paroxysmal atrial fibrillation	NACA CEP68 ARNT2 CREB5 ZFHX3	6.65e-03	156	222	5	C0235480
Disease	familial atrial fibrillation	NACA CEP68 ARNT2 CREB5 ZFHX3	6.65e-03	156	222	5	C3468561
Disease	Persistent atrial fibrillation	NACA CEP68 ARNT2 CREB5 ZFHX3	6.65e-03	156	222	5	C2585653
Disease	Multiple congenital anomalies	SETBP1 AFF4	7.11e-03	17	222	2	C0000772
Disease	Hypogammaglobulinemia	BACH2 CD79A	7.11e-03	17	222	2	C0086438
Disease	Atrial Fibrillation	NACA CEP68 ARNT2 CREB5 ZFHX3	7.38e-03	160	222	5	C0004238

Protein segments in the cluster

Peptide	Gene	Start	Entry
VQDPGFPMGISTLAP	UMODL1	471	Q5DID0
GIPGVPSLAVVPSDM	ZNF280A	186	P59817
PIQVPMVAGSPLGAT	BANP	91	Q8N9N5
MDLPTASSINPAPLG	BACH2	736	Q9BYV9
GPISTTPGIIPQKMS	CCNT2	421	O60583
AATGEVDLLPMPGPN	CLSTN3	311	Q9BQT9
FSVLGPSGPILAMVG	BTN3A3	31	O00478
MDGGQPIPSSLVPLG	CTXN3	1	Q4LDR2
EPALSGLPPATMGSG	CEP68	96	Q76N32
SAFLVPMPTPGLTLG	ACADS	211	P16219
FSVLGPSGPILAMVG	BTN3A1	31	O00481
GVASPTITVAMPGVP	BAG6	626	P46379
VPMTELKPGNPASGH	ALLC	136	Q8N6M5
GPSSPQTGMTLILGP	ALPK2	421	Q86TB3
TITVPPALPAAMTAG	ATP13A3	451	Q9H7F0
PVDGGVTNMQSLPPA	FCHO2	711	Q0JRZ9
TASPNAPKLGPMELA	ACVR1C	101	Q8NER5
GLSQEVPTMPSLPGT	ALPK3	1061	Q96L96
NVQLVPSAMPPSGGV	ARID2	1126	Q68CP9
MKVPAPGQPGEAALL	CARNS1	11	A5YM72
KGPGVDLPSVNLSMP	AHNAK	5281	Q09666
VPPSPAMAASKALGS	SNAP91	741	O60641
MPGGPGVLQALPATI	CD79A	1	P11912
ALPGPPAQLMDSSAV	RAD54L2	1201	Q9Y4B4
MAVLAAGALTQPVPP	CCK	11	P06307
APAPGQTLNLPVMGV	DENND6B	196	Q8NEG7
HPMSVTVSAPKPALG	CECR2	941	Q9BXF3
GLTPSAMTAGALPPG	FAM193A	421	P78312
VGAAMASAIAPPPGV	ARMCX2	131	Q7L311
APSPGLGSKAVGMPS	AFF4	1041	Q9UHB7
VGMPSPVSPKLSPGN	AFF4	1051	Q9UHB7
IPGSVTLPVAPMAAT	ARNT2	16	Q9HBZ2
VLPKGGNTPAPAESM	C9orf152	61	Q5JTZ5
LGDVSKNMAPLPSAP	NKX2-1	146	P43699
LPLDSSPVLMAQGPS	RAB19	196	A4D1S5
LSPGGPTALAMKQEP	NSD1	116	Q96L73
LEPTGMNQPGLVPAS	QRICH2	226	Q9H0J4
MASSQGGPALLQPVP	RFWD3	26	Q6PCD5
PNPLATGPLGVCTMS	EGR2	141	P11161
GQEPLTASMLASAPP	PABPC1	541	P11940
LSVQPGPMVAPGESL	LILRA2	226	Q8N149
ELPVPGLSQAATMPA	NPAS2	451	Q99743
GPAPARPKMLVISGG	ARHGEF17	2016	Q96PE2
TDPNKVVVMPGSGAP	MDGA1	921	Q8NFP4
GTLPNPTMPGSSAVL	CREB5	181	Q02930
PGIVVTPMGSGSNRP	FBXO22	151	Q8NEZ5
TKPPVPRVSPAMGGQ	MAML1	821	Q92585
AIPTLPVSPGASKML	MUC16	11446	Q8WXI7
SSPTIMAAGPLLVPF	MUC16	12376	Q8WXI7
KGLQTVGCMPPPVSS	SLC10A7	106	Q0GE19
PGFVGSPLAAMNPKL	PATL1	286	Q86TB9
LAGHSVQGGMALPPP	PBX3	16	P40426
PPATLASSMGNLPEV	POC1A	316	Q8NBT0
STPMLPPVGVQAVAL	DCC	841	P43146
SPGMVSVGPLPKAEA	PTPRN	226	Q16849
KPGTFLSPMGVPRAG	KLHL33	396	A6NCF5
AAGVVPSRVKATPMP	MAP4	881	P27816
GPMVSAPVKDQGPIV	MAP6	596	Q96JE9
PGQMAGTPITPLKDG	GORASP2	216	Q9H8Y8
IPQVQSSGVPGAMSP	PSMG3-AS1	171	Q96PY0
TTMVPTAALAKPHGP	GPAA1	526	O43292
EPVPGTNPSILMGAQ	GREB1	241	Q4ZG55
LKPVGVMAPASGPAS	WWC1	796	Q8IX03
MAPAPVTLLAPGAAS	MST1L	1	Q2TV78
GVAPGAPLVSMAPRI	HMCN2	421	Q8NDA2
GVPISAMFITPGVTP	SMPDL3B	291	Q92485
LISAPAGPDGVTSPM	FREM2	2436	Q5SZK8
NPVAPIKTPMIAGGL	GALNT2	296	Q10471
MGTAQSIGLKPGPVP	BSN	1821	Q9UPA5
AVPVQKSGTSGVPPM	KIFC1	111	Q9BW19
VSMPPKGDSGQPLFL	CPVL	31	Q9H3G5
SPEVQGAMGSPAPKR	HR	416	O43593
GKMALNSPQPGPVES	IRAG1	306	Q9Y6F6
MDLPVGPGAAGPSNV	HSF1	1	Q00613
SGQLGDIRKMPPAPS	PCLO	1116	Q9Y6V0
MSGPGTAAVALLPAV	FGF4	1	P08620
AGLPTTLGPAMVTPG	MTSS1	571	O43312
KAVPVPNMTPSGVGR	PDXDC1	406	Q6P996
VGGAVLVSPSKMKPP	MDM1	536	Q8TC05
NSMGIKRPAPQPASG	DDHD2	446	O94830
GSPAMLPVQPAKLTP	PMS2P5	91	A8MQ11
SLSVQPGPVMAPGES	LILRB2	226	Q8N423
GTAGLGPPATVMAKP	MNT	531	Q99583
GPPATVMAKPAVGAQ	MNT	536	Q99583
GSPMIVGSPRALTQP	MYADM	21	Q96S97
LAPTAQPGAPSMAGT	MED25	356	Q71SY5
SVLTSVPGGPPMVCL	KMT2B	1191	Q9UMN6
PGQEPLTASMLAAAP	PABPC1L	526	Q4VXU2
PAPVSAVPTGLHSKM	NPTXR	221	O95502
GIQPPAMSTPVCALG	NUP155	626	O75694
VAPGTPTMGAPKTVD	SBF1	1816	O95248
LGLIPAPSMVPATDT	POM121B	246	A6NF01
MAVVLNGGTIPTAPP	GPRC5B	381	Q9NZH0
LQPPPAQGSLGTMTA	NCOA6	326	Q14686
APQMKSLQGGPSRVP	NCOA6	401	Q14686
NSGLMPPSVAVVGPL	NCOA6	1686	Q14686
GSPLRPGLATMGTQP	GATA2	226	P23769
PMEPQGVTGAPATHI	GASK1A	46	Q9UFP1
VMVPAKPGSGAPARA	DPYSL4	506	O14531
CPTNGPKIPSIATGM	EGFR	636	P00533
KMQGQSPPAPTRGIS	CKAP5	811	Q14008
KTAAGVMPSAPAIPG	CDHR2	1196	Q9BYE9
TSGLPPPRTAMLDGN	GABRR1	386	P24046
MSGPRPVVLSGPSGA	GUK1	1	Q16774
PVSLMVPSQAGAPGR	CACNA1C	2096	Q13936
AAGQTPKVVPAMSPT	E2F2	11	Q14209
NPSVAMAIAGGPLAP	DOCK6	1211	Q96HP0
AMFQGPLTPLATVPG	DAB1	411	O75553
SPGMVELKAPQNSGP	GFY	326	I3L273
NMPGIPLTGLVGFPA	CHD6	2486	Q8TD26
NVPVLPPAMNTGGSL	CRTC2	261	Q53ET0
NEPGSSIMPGKVNPT	FH	361	P07954
APSMPASPVLTKAGI	FNDC3A	466	Q9Y2H6
ESPPSQAVGKGLLPM	POLQ	2266	O75417
LTAVAPVPMGSIPVV	ITSN1	126	Q15811
PSGLFIPSMAVGAIA	CLCN5	521	P51795
GEPGSIIMSSLPGPK	COL4A5	156	P29400
SDVSGRLMGSPPVPG	FBXO28	226	Q9NVF7
GAVRKPVVPSVPMAS	DIDO1	636	Q9BTC0
HMAVGGPAQTPLLPA	COL27A1	311	Q8IZC6
FSVLGPSGPILAMVG	BTN3A2	31	P78410
GVVMASSPALPTQPA	CREB1	251	P16220
MIPGGLSEAKPATPE	CSTA	1	P01040
MPVGGLLPLFSSPAG	MAN1A1	1	P33908
MVSNPVHGLPFLPGT	EFHC1	1	Q5JVL4
MIPGNPSPGADLAVS	GCRG224	1	Q8WZA8
ALSPGGPVAVPMSLG	INHA	156	P05111
SLPGPTGKPALEFVM	IPO9	826	Q96P70
LTGGMPFIDVPTPIS	GBF1	261	Q92538
LVSPPAVSAGGVPPM	KLF10	256	Q13118
LRMPPNGLPVSASTG	KLF17	151	Q5JT82
GIQDQPVALPPSSGM	KMT2A	3391	Q03164
PVKVAGAPGTLMTAP	DALRD3	316	Q5D0E6
QPLPFPGMDKSGAAV	CPSF4	26	O95639
RKTTPANPVGPSGGM	COG2	671	Q14746
PAMDRPLQPGSATGI	HDAC9	621	Q9UKV0
GGSEVGPPPAQAMKL	BBS1	411	Q8NFJ9
SLKPGQGLIMEAAPP	C4orf54	136	D6RIA3
VPTDGLAPLTATMAP	COL15A1	481	P39059
LQALTMTNSGAPPPG	CREM	191	Q03060
MTNSGAPPPGATIVQ	CREM	196	Q03060
EVMQLGSSSPPPARG	PWWP2B	76	Q6NUJ5
SGMQISGAVAPAPPS	SEC24C	141	P53992
PGMVGPVIAKSLTPD	SLC17A5	436	Q9NRA2
GHAVPPTLVPLMNGS	IRF2BP2	181	Q7Z5L9
NSEIPMIPGAHPKGS	PRRT3	36	Q5FWE3
MIPGAHPKGSVGSEP	PRRT3	41	Q5FWE3
PLQMTIPGGTPSLKI	FAM120B	666	Q96EK7
VSPGLPQRPASAGAM	MEF2D	191	Q14814
LGMKPPSPGTVLALA	OTUD5	471	Q96G74
PVSGMITIPAASLAG	NFYA	186	P23511
PTGAASIVPSVPGMA	OAS3	391	Q9Y6K5
GALQAALMSPPPAAA	FOXF2	21	Q12947
PVAIFCLPGTAMGPN	FUT1	51	P19526
ATGSPRPGLMAVEPV	FUT5	41	Q11128
TTMGPLPPFAVAQGA	PVR	281	P15151
LGLSTAAVGAMAPPA	AHCYL2	31	Q96HN2
PHGTVATPVFMPVGT	QTRT1	36	Q9BXR0
PMSGLGSVPIPLQQA	SYNE1	7586	Q8NF91
VMEKGPLPSPTAGLE	PLEKHG3	1146	A1L390
TSPGLNPMTPVHKGA	RIF1	386	Q5UIP0
QLASAVAGVMPGGPP	POU6F2	101	P78424
MSPLQGPVSPATSLG	PRR36	461	Q9H6K5
PLSLTPTGQGGEAMP	NCAN	681	O14594
MAATLGAGTPPRPQA	EPPK1	26	P58107
LGSSVMAPVGPPRSE	SIPA1L1	46	O43166
VSSPVMVAQGGGPTP	STARD9	1956	Q9P2P6
QTPPLKGCPTVMAGD	TDRD7	326	Q8NHU6
NVSLPPTEAGMAPAV	ITGA2B	601	P08514
PGTEMALGAKPSAPV	SIRPG	136	Q9P1W8
PKVPFGQPGAMADQS	ARHGAP44	656	Q17R89
SAPKAGLPGATGPMA	SCARF1	756	Q14162
SDGIFPGMSGPPLVL	AARS2	336	Q5JTZ9
TAVSGPGPGQMVAPV	SDCBP2	76	Q9H190
ARIMLFTGGPPTQGP	SEC23B	286	Q15437
PAPGLVPGIPSVASM	ARHGAP22	496	Q7Z5H3
PGSAQPGMAKVLQPR	SHANK2	1586	Q9UPX8
AAVGAPVMSPLSPGE	AHNAK2	4886	Q8IVF2
GVPALGFSPMNRTPV	ACY1	356	Q03154
PSSLFGMAGQVPPLQ	AGFG2	331	O95081
TASPVIPGEPMKLSG	CIART	316	Q8N365
AGAIAGMPAASLVTP	SLC25A13	526	Q9UJS0
PPVKMQGSITTPGSI	CNOT1	1001	A5YKK6
LPMPQGVAQTGAPSK	INPP5J	21	Q15735
VGQLVMSASAGPKPP	INPP5J	111	Q15735
PDMALPRLGTQSTGP	INPP5J	366	Q15735
LGTMKPEPAPTSAGA	TNRC18	616	O15417
PPTMAPGLAQPKAIA	ULBP3	211	Q9BZM4
KTSEMPPVPGGLSLE	TIGD3	376	Q6B0B8
PAGAKPGIADSVMEP	PHC2	276	Q8IXK0
KPASEPVHMTGPVGS	TRMO	421	Q9BU70
GPTMPQTLAGLSPGA	ZFHX4	3251	Q86UP3
PPVSLVSGGLSPAMD	USP43	1021	Q70EL4
VAGQSLPGPMVDQSP	ZBTB16	171	Q05516
ADVGMAGPPQKSPAT	NOD2	261	Q9HC29
SQLEPGLEKPPGATM	RP1L1	1471	Q8IWN7
TTKTGVLPGMAPPIV	TCERG1	396	O14776
VTLGPSGILESPMAP	RREB1	981	Q92766
LQTSTPIGAMGTPAP	SPATC1	281	Q76KD6
MGGSTPVLTPGKTPI	SF3B1	346	O75533
PVLTPGKTPIGTPAM	SF3B1	351	O75533
MSQPPIGGAAPATAA	SOGA3	1	Q5TF21
APGIPSGMETLKDTP	SULT1A1	86	P50225
VPGIPSGMETLKNTP	SULT1A2	86	P50226
PNLVPGVGASMFNTP	UBQLN1	361	Q9UMX0
TPPGLAPGVSSFLQM	VPS16	211	Q9H269
PPSLLQGEVMGTPSS	VWCE	356	Q96DN2
PPTLAPGMTLAPVQG	PHC1	586	P78364
PLMNSGTTDAPVRPG	RFPL2	361	O75678
GLPAPPSIIKAMGGS	MPL	131	P40238
PAATSPLSPMANGGR	PHLDB1	216	Q86UU1
IMQLLGAFPSPSGPA	RALGAPB	906	Q86X10
SEGTKPPLPMGSQVL	TSHZ2	551	Q9NRE2
SLEPPMAAAFGAPGI	PTBP3	286	O95758
LSQPLPGPVGSSAMT	UNKL	486	Q9H9P5
PAMPGVNNLTGLTFP	TLX1	161	P31314
TSKCPGTMEPIALPG	TRAPPC9	511	Q96Q05
MSKVTAPGSGPPAAA	USP31	1	Q70CQ4
IDLGPGSPAVVSPMV	TOM1L2	331	Q6ZVM7
GSPAVVSPMVGNTAP	TOM1L2	336	Q6ZVM7
DPVVPLQGVPSMFGT	HIVEP2	676	P31629
GDMQPSLNPPKVGSA	SETBP1	1126	Q9Y6X0
ALSPTSMGPQPITLG	TMEM119	61	Q4V9L6
LILQGPDDGAPMTSP	ZNF335	166	Q9H4Z2
GPTNVSLTVTNMPPG	MST1R	651	Q04912
MAKGGEALPQGSPAP	UBQLN3	1	Q9H347
RGPAMAVSPLGAVPK	TYSND1	201	Q2T9J0
TPGAPPLAGMAIVKE	TRIM28	541	Q13263
SQVPTESVGMPPLGN	ZFHX3	1681	Q15911
ESLQVLPSGTPPGTM	TMEM108	36	Q6UXF1
PPMLSPVRQGSGLFS	TRERF1	711	Q96PN7
FMSIPMTVGPPIAGL	SLC16A10	426	Q8TF71
VPGLVPPAPRATGMS	LRP4	1651	O75096
GGVPFQSVLVNMPTP	NACA	1851	E9PAV3
DPLVTGAPGAPMDLQ	MYOM2	376	P54296
SAGLGQPSMPTDPVL	MYOM3	881	Q5VTT5